[
    {
        "pmid": "40818935",
        "title": "Exploring the gut microbiota associated with peripheral nerve invasion in colorectal cancer patients and constructing predictive models.",
        "abstract": "study aim explore difference composition abundance biological function gut microbiota colorectal cancer CRC patient peripheral nerve invasion PNI without peripheral nerve invasion NPNI Additionally tried construct machinelearning predictive model incorporating identified microbiota characteristic explore impact gut microbiota CRCPNI progression search new noninvasive microbiological indicator CRCPNI Finally successfully developed predictive model predict PNI CRC patient leveraging microbial biomarkers innovative approach expected offer novel strategy early detection CRC metastasis thereby facilitating informed decision regarding treatment options study included 132 colorectal cancer CRC patients divided two separate group according whether exhibited PNI gut microbiota participant subjected 16S rRNA gene sequencing followed thorough analysis identify significant difference groups applied cell sorting algorithm convert transcriptome sequencing data obtained 8 colorectal cancer patient matrix representing immune cell abundance Following this matrix utilized investigate association among PNIrelated distinct gut microbiota immune cells immunerelated genes PNIrelated differentially expressed gene or molecular markers pathways well association KEGG pathways Based differential gut microbiota constructed Random Forest RF Multilayer Perceptron MLP model predict PNI CRC patients Comparative analysis αdiversity βdiversity gut microbiota CRC patient without PNI revealed statistically significant difference P  005 However Linear Discriminant Analysis effect size LEfSe identified 35 distinct gut microbiota 28 specie enriched PNI group 7 specie significantly enriched NPNI group analyzing gut microbiota significantly associated PNI successfully constructed predictive model using RF MLP predict occurrence PNI CRC patients model demonstrated robust performance PNI NPNI groups 35 gut microbiota specie exhibited significant variation abundance differential intestinal microbiota associated PNI colorectal cancer may modulate neuroinvasion process via variety potential biological mechanisms RF MLP predictive model show considerable accuracy predicting CRCPNI status reference value",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818935/",
        "source_type": "Global"
    },
    {
        "pmid": "40817159",
        "title": "The lung immune prognostic index stratifies the occurrence of checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients: a multi-institutional cohort study.",
        "abstract": "Lung immune prognostic index LIPI associated survival outcome patient nonsmall cell lung cancer NSCLC receiving immunotherapy association occurrence checkpoint inhibitor pneumonitis CIP unclear retrospectively included 1824 patient advanced NSCLC received immune checkpoint inhibitor ICIs two institutions Cox regression analysis cumulative incidence curve used evaluate predictive value LIPI Additionally performed competing risk analysis using FineGray regression cumulative incidence curves median followup 15 months 99 patient developed CIP Compared good LIPI group intermediate LIPI group HR 187 P  0007 poor LIPI group HR 439 P  0001 higher risk CIP Furthermore found LIPI independent predictor intermediategrade CIP intermediate LIPI HR 211 P  0056 poor LIPI HR 451 P  0002 highgrade CIP intermediate LIPI HR 694 P  0014 poor LIPI HR 4401 P  0001 lowgrade CIP intermediate LIPI HR 131 P  0392 poor LIPI HR 072 P  0656 Similar result obtained competing risk analysis LIPI grade show potential predicting risk CIP immunotherapy could valuable clinical management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817159/",
        "source_type": "Global"
    },
    {
        "pmid": "40817111",
        "title": "Individual-level characteristics and geospatial factors associated with cervical cancer screening participation in Alberta, Canada: a population-based cross-sectional study.",
        "abstract": "Cervical cancer fourth common cancer woman worldwide Effective primary prevention human papillomavirus vaccination secondary prevention screening prevent cervical cancer cases Cervical cancer screening uptake varies among woman underserved populations Research add understanding individual geographic arealevel characteristic woman screening status valuable public health intervention planning study aimed identify characteristic related cervical cancer screening status study population included woman age 28 69 year Alberta Data extracted administrative health data source linked Alberta Cervical Cancer Screening Program database determine screening status Descriptive bivariate analysis conducted describe variation cervical cancer screening status individuallevel sociodemographic health system factors geographic characteristics Multinomial logistic regression analysis conducted investigate relationship characteristic screening participation Geospatial analysis including heat map used visualize variation screening participation across province GetisOrd Gi hotspot analysis used determine location magnitude spatial autocorrelation study included 933965 eligible women Compared currently uptodate screening record screening tend older OR 363 95 CI 357 370 reside South Zone OR 151 95 CI 147 155 health system nonusers OR 295 95 CI 286 304 see general practitioner OR 1386 95 CI 1332 1443 usual provider care OR 3227 95 CI 3141 3315 statistically significant hot spot woman overdue record cervical cancer screening North Central Calgary Zones study found cervical cancer screening participation varied across geographical health system sociodemographic characteristic identified cluster region higher proportion woman underscreened Alberta Canada Overall finding help inform design intervention aim improve cervical cancer screening participation among underserved groups",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817111/",
        "source_type": "Global"
    },
    {
        "pmid": "40815354",
        "title": "Impact of COVID-19 on live birth and perinatal outcomes following subsequent frozen-thawed embryo transfer.",
        "abstract": "evaluate whether prior SARSCoV2 infection adversely affect live birth perinatal outcome following subsequent frozenthawed embryo transfer FET investigate whether time interval infection embryo transfer influence pregnancy outcomes retrospective cohort study woman tested positive SARSCoV2 FET designated infected group n  1081 asymptomatic testnegative woman included control n  865 infected group subdivided four subgroup according time interval infection FET ≤ 30 3160 6190 ≥ 91 days Overall positive HCG rate significantly lower infected group compared noninfected group 629 vs 675 adjusted  080 95 CI  066097 P  0021 significant difference observed live birth rate 459 vs 497 adjusted  084 95 CI  070101 P  0062 significant difference clinical pregnancy pregnancy loss measured obstetric neonatal outcome groups However woman ≤ 30 days subgroup associated significant reduction positive HCG adjusted  052 95 CI  033084 P  0007 clinical pregnancy adjusted  060 95 CI  038095 P  0029 live birth rate adjusted  051 95 CI  031083 P  0006 compared noninfected group association observed subgroups undergoing FET overall prior SARSCoV2 infection adversely affect live birth perinatal outcomes However considering decreased likelihood live birth among woman shorter intervals delaying subsequent FET least 30 day infection could beneficial",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815354/",
        "source_type": "Global"
    },
    {
        "pmid": "40815154",
        "title": "Recent advances in exercise immunometabolism: Immune cell bioenergetics, muscle-immune cell interactions, and potential dietary adjuvants.",
        "abstract": "Exercise profoundly alters immunological process improve overall health immunity link immune cell metabolism function prompted study immune cell bioenergetics following acute exercise role muscleresident immune cell training adaptations review highlight recent work area discusses potential dietary approach boosting exerciseinduced immunometabolic benefits Human study highlight ability exercise alter immune cell bioenergetics also reporting accompanying change immune cell function Rodent study involving moderate exercise report improved innate adaptive immune cell phenotype accompanied increased mitochondrial size bioenergetic function Various muscle resident immune cell subpopulation including macrophages mast cells regulatory cell also appear involved adaptive response exercise Fasting exogenous ketones mitochondrial enhancing compound eg sulforaphane urolithin A could theoretically potentiate immunometabolic benefit exercise based independent effects evidence combined intervention currently lacking Exercise dietary manipulation independently alter immunometabolic pathway could combined maximize associated health benefits may benefit cannot meet physical activity guideline want maximize exercise adaptation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815154/",
        "source_type": "Global"
    },
    {
        "pmid": "40813745",
        "title": "An Analysis of Dental Hygienists' Practices and Perceptions Toward HPV Vaccination.",
        "abstract": "Human papillomavirus HPV common sexually transmitted infection United States cause anogenital oropharyngeal cancers HPVrelated cancer preventable vaccination vaccine initiation completion rate remain suboptimal compared vaccines Provider recommendation strongest predictor vaccine uptake oral health provider wellpositioned recommend HPV vaccination patient given connection HPV oropharyngeal cancers may face unique barrier implementation Previous study focused primarily improving dental hygienists knowledge confidence regarding HPV vaccination discussion rather examining HPV vaccine belief impact practice behaviors study sought assess dental hygienists belief behavior related HPV vaccine education guidelines Data collected dental hygienist attended HPVrelated continuing education CE course large regional dental conference Approximately 26 participant discussed HPV oral cancer patients 16 provided HPV vaccine education 15 recommended vaccine patients Many believe patient would follow HPV vaccine referral primary care 59 felt patient would receptive dentist referred vaccine compared dental hygienist 39 22 p  00001 rate HPVrelated cancer continue rise necessary continue developing strategy help dental hygienist become comfortable HPV cancer prevention Future research consider behavioral target shift attitude behavior toward HPV vaccine education guideline implementation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813745/",
        "source_type": "Global"
    },
    {
        "pmid": "40813693",
        "title": "The role of skin testing, drug challenge and IFN-γ ELISpot in delayed hypersensitivity to iodinated contrast media.",
        "abstract": "use vivo ex vivo diagnostic tool delayed hypersensitivity reaction DHRs associated iodinated contrast medium ICM currently illdefined evaluate role vivo ex vivo diagnostic tool DHRs occurring 6 h following intravenous lowosmolality ICM conducted prospective multicenter international cohort study patient recruited two tertiary care adult allergy clinics Austin Health Australia McGill University Health Centre Canada Eligible participant adult reported DHR receiving ICM vivo testing skin testing intravenous challenge performed identify alternative agent Ex vivo testing using interferonγ enzymelinked ImmunoSpot assay performed four Australian patient explore diagnostic performance culprit ICM identified dIDT 1720 85 320 15 challenge necessary confirm delayed hypersensitivity patient positive dIDT iohexol positive iodixanol 1515 100 34 75 34 75 46 67 35 60 positive iopromide ioversol iopamidol iobitridol respectively Overall 720 35 patient tolerated challenge alternative ICM IFNγ release assay negative implicated ICM 4 patient confirmed DHR positive dIDT dIDT allowed confirmation cellmediated allergy implicated ICM 85 patient strong clinical suspicion DHR identification noncrossreactive ICM 35 patients IFNy ELISpot useful four patient tested",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813693/",
        "source_type": "Global"
    },
    {
        "pmid": "40806058",
        "title": "Histamine Metabolism in IBD: Towards Precision Nutrition.",
        "abstract": "Patients Inflammatory Bowel Disease IBD exhibit dysregulated immune response may exacerbated bioactive compounds histamine Current dietary guideline IBD primarily focus symptom management flareup prevention yet targeted nutritional strategy addressing histamine metabolism remain largely unexplored narrative review aim summarize existing literature complex interplay IBD histamine metabolism propose novel dietary framework managing IBD progression patient histamine intolerance HIT Relevant study identified comprehensive literature search PubMedMEDLINE Google Scholar ScienceDirect Scopus Web Science proposed lowhistamine diet LHD aim reduce overall histamine burden body two primary strategies 1 minimizing exogenous intake limiting highhistamine histaminereleasing food 2 reducing endogenous histamine production modulating gut microbiota composition specifically targeting histamineproducing bacteria parallel identifying individual histamineintolerant understanding role histaminedegrading enzymes diamine oxidase DAO histamineNmethyltransferase HNMT emerging important area focus Despite growing interest role histamine mast cell activation gut inflammation clinical trial investigated effect lowhistamine diet IBD populations Therefore future research prioritize implementation LHD intervention IBD patient evaluate generalizability clinical applicability",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806058/",
        "source_type": "Global"
    },
    {
        "pmid": "40801169",
        "title": "Interventions for anal canal intraepithelial neoplasia.",
        "abstract": "Anal intraepithelial neoplasia AIN dysplasia anal transitional epithelium associated human papillomavirus HPV infection Highgrade lesion potential develop anal cancer incidence prevalence anal cancer increasing last decades Certain group  including people living HIV men sex men MSM suppressed immune system  high risk developing AIN Targeted excision using ablative treatment electrocauterisation infrared coagulation cryotherapy used firstline therapeutic strategies option include topical treatment immunomodulators imiquimod cytostatics fluorouracil Ideally treatment low risk complication result low risk recurrence first update review originally published 2012 assess effect therapeutic intervention anal intraepithelial neoplasia regardless gender age comorbidity used CENTRAL MEDLINE Embase five trial registers together reference checking citation searching contact study author identify study included review latest search date 16 April 2025 included randomised controlled trial RCTs assessed type intervention AIN excluded clusterrandomised crossover trials excluded people histological diagnosis anal carcinoma Pagets disease Bowenoid papulosis used standard methodological procedure expected Cochrane primary outcome interest were eradication defined absence histologic criterion presence normal epithelium scarring complete absence dysplasia development anal cancer human papillomavirus HPV eradication assessed certainty evidence using GRADE Five RCTs met inclusion criteria randomising total 4907 participants included participant adult living HIV CD4 cell count 300 cellsμL median participant age ranged 45 51 years participant male Two study multicentre conducted USA remaining study conducted outpatient clinic Spain Netherlands UK considered overall risk bias high one study moderate four main reason concern bias openlabel design high dropout rates study different intervention outcomes precluding metaanalysis inclusion two multiarmed study mean synthesised evidence nine separate comparisons Here summarise result largest study 4459 randomised participants comparing highresolution anoscopyguided treatment active monitoring summarise result study main review study comparing highresolution anoscopy HRAguided treatment active monitoring assess four reviews outcome interest eradication HPV eradication histological downgrading lesions recurrence AIN Results three remaining outcome  development anal cancer quality life adverse event  follows HRAguided treatment group four per 1000 04 participant developed anal cancer active monitoring group nine per 1000 09 participant developed anal cancer median followup 25 28 month risk ratio RR 043 95 confidence interval CI 020 093 P  003 1 study 4446 participants lowcertainty evidence active monitoring group increased impact psychological function inclusion 28 day inclusion treatment group difference physical symptoms impact physical functioning impact psychological functioning inclusion 28 day inclusion Two per cent participant treatment arm 02 active monitoring arm reported adverse events adverse event mild pain RR 107 95 CI 385 2979 P  0001 1 study 4446 participants lowcertainty evidence included study focused people living HIV may limit applicability result HIVnegative people assessed certainty evidence low outcome across nine comparisons highlighting lack highquality evidence intervention AIN finding suggest HRAguided treatment may lower anal cancer risk evidence uncertain evaluated efficacy cidofovir sinecatechins infrared coagulation HRAguided electrocautery imiquimod fluorouracil eradicating AIN eradication rate 14 62 followup period ranging four week 33 months evidence effectiveness treatment uncertain study intervention sufficient power duration required determine efficacy interventions Studies addressing treatment HIVnegative cohort also needed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40801169/",
        "source_type": "Global"
    },
    {
        "pmid": "40797037",
        "title": "Risk factors of cytomegalovirus reactivation in patients with rheumatic musculoskeletal diseases undergoing remission induction therapy with high-dose glucocorticoids; a prospective short-term cohort study.",
        "abstract": "elucidate risk factor cytomegalovirus CMV infection involvement immunity status CMV infection patient rheumatic musculoskeletal disease remission induction therapy Patients rheumatic musculoskeletal disease underwent induction therapy highdose glucocorticoid consecutively enrolled patient screened CMVIgG baseline monitored weekly CMV pp65 antigen polymorphonuclear leukocyte peripheral blood discharge titre antibody individual viral antigen examined using cellbased flow cytometry total 157 patient 136 CMVIgGpositive 21 CMVIgGnegative enrolled CMV infection occurred 52 331 patients CMVIgGpositive 382 CMVIgGpositive patients Multivariable analysis revealed initial prednisolone dose  091 mgkgday odds ratio OR 45 P  001 intravenous cyclophosphamide OR 33 P  001 diabetes mellitus OR 48 P  001 history malignancy OR 26 P  004 independent relevant risk factor CMV infection titre CMVIgG antibody individual CMV antigen significant CMV infection lymphocyte count significantly decreased baseline CMV infection 985µL v 622µL P  003 CMV infection group treated antiCMV agents risk factor CMV infection shortterm initiation induction therapy patient rheumatic musculoskeletal disease treatment regimen comorbidities Decreased lymphocyte count relevant humoral immunity CMV infection necessity antiCMV agents Key Points • CMV infection remission induction therapy caused reactivation latent infection • risk factor shortterm CMV infection include treatment regimen comorbidities • Decreased lymphocyte count relevant humoral immunity CMV infection necessity antiCMV agents",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797037/",
        "source_type": "Global"
    },
    {
        "pmid": "40796288",
        "title": "[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)].",
        "abstract": "standardize lung cancer prevention treatment measure China enhance quality diagnosis treatment improve patient prognosis provide evidencebased medical guidance clinician levels Chinese Medical Association convened expert respiratory medicine oncology thoracic surgery radiotherapy imaging pathology develop Chinese Medical Associations Clinical diagnosis treatment guideline lung cancer 2025 edition consensus resulted several update 2024 version screening section new recommendation added specify population advised undergo lung cancer screening also emphasizes individual high risk lung cancer fully informed potential benefit risk lowdose CT LDCT screening undergoing examination advancement treatment options update made recommended genetic testing patient early midstage postoperative advanced nonsmall cell lung cancer NSCLC patient advanced epidermal growth factor receptor EGFR mutations addition broader range monotherapy options application combination therapy may offer better disease control certain patients Furthermore treatment option approved patient undergoing immunotherapybased neoadjuvant treatment develop resistance EGFR tyrosine kinase inhibitor TKIs patient previously limited treatment options KRAS G12C mutations HER2 mutations small cell lung cancer resistance development approval novel drug brought significantly improved efficacy prognosis recommendation based stateapproved drug applications international guidelines current clinical practice China integrating latest evidencebased medical research screening diagnosis pathology genetic testing immune molecular marker detection treatment methods followup care goal provide comprehensive reasonable recommendation clinicians imaging specialists laboratory technicians medical staff levels",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796288/",
        "source_type": "Global"
    },
    {
        "pmid": "40796286",
        "title": "[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)].",
        "abstract": "standardize lung cancer prevention treatment measure China enhance quality diagnosis treatment improve patient prognosis provide evidencebased medical guidance clinician levels Chinese Medical Association convened expert respiratory medicine oncology thoracic surgery radiotherapy imaging pathology develop Chinese Medical Associations Clinical diagnosis treatment guideline lung cancer 2025 edition consensus resulted several update 2024 version screening section new recommendation added specify population advised undergo lung cancer screening also emphasizes individual high risk lung cancer fully informed potential benefit risk lowdose CT LDCT screening undergoing examination advancement treatment options update made recommended genetic testing patient earlyand midstage postoperative advanced nonsmall cell lung cancer NSCLC patient advanced EGFR mutations addition broader range monotherapy options application combination therapy may offer better disease control certain patients Furthermore treatment option approved patient undergoing immunotherapybased neoadjuvant treatment develop resistance epidermal growth factor receptor EGFRtyrosine kinase inhibitor TKI patient previously limited treatment options KRAS G12C mutations HER2 mutations small cell lung cancer resistance develops approval novel drug brought significantly improved efficacy prognosis recommendation based Stateapproved drug applications international guidelines current clinical practice China integrating latest evidencebased medical research screening diagnosis pathology genetic testing immune molecular marker detection treatment methods followup care goal provide comprehensive reasonable recommendation clinicians imaging specialists laboratory technicians medical staff levels",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796286/",
        "source_type": "Global"
    },
    {
        "pmid": "40791600",
        "title": "The Role of SR-BI in sepsis: leveraging mechanistic insights to advance precision steroid therapy.",
        "abstract": "According Surviving Sepsis Campaign 503 septic shock patient received steroidglucocorticoid GC therapy However whether GC therapy beneficial might benefit hotly debated Initial guideline recommended GC therapy septic patient adrenal insufficiency since retracted Recent study using animal model adrenal insufficiency shed light mechanisms demonstrating adrenal stress response part host response essential control inflammatory response sepsis adrenal insufficiency risk factor sepsis perspective review explores limitation GC therapy lens GC biology particular focus role scavenger receptor class B type SRBI mediating adrenal stress response highlight mechanism SRBImediated adrenal stress response contributes regulation hyperinflammation innate immune responses integrating mechanistic insight limitation GC therapy advocate precision medicine approach GC therapy sepsis selectively applying GC therapy patient adrenal insufficiency without",
        "mesh_terms": [
            "Humans",
            "Sepsis",
            "Animals",
            "Precision Medicine",
            "Adrenal Insufficiency",
            "Glucocorticoids"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791600/",
        "source_type": "Global"
    },
    {
        "pmid": "40789765",
        "title": "Genetic etiologies associated with non-immune hydrops fetalis delineated by whole exome sequencing: A pilot series and its implications in prenatal genetic counseling.",
        "abstract": "Nonimmune hydrops fetalis NIHF spectrum disease involving heterogeneous etiologies Prenatal application whole exome sequencing WES emerged valuable tool decipher genetic cause structural abnormality detected fetal ultrasound Here reviewed index case NIHF whose genetic etiology delineated WES conducted retrospective study pilot series n  12 NIHF underwent WES outcome systematically reviewed case performed detailed sonographic examination anasarca virology profile karyotyping chromosomal microarray analysis CMA addition WES performed either prenatally postnatally December 2019 July 2024 12 fetus abnormal fluid accumulation fetal compartments despite normal karyotyping CMA underwent WES elucidate potential genetic etiologies Variant interpretation performed accordance guideline American College Medical Genetics Genomics ACMG definitive molecular diagnosis established 12 cases identified disorder including lymphatic abnormality 33 musculoskeletal disorder 30 syndromic condition 17 recurrent case 33 100 received fetal therapy 44 100 definite molecular diagnosis Two survived fetus diagnosed first third trimesters respectively four infant died six couple decided terminate pregnancy due disease progression Two novel founder variant HSPG2 BBS2 found WES effective tool determine genetic diagnosis NIHF case would discover novel causative gene match prenatal phenotype exhibited",
        "mesh_terms": [
            "Humans",
            "Hydrops Fetalis",
            "Female",
            "Pregnancy",
            "Exome Sequencing",
            "Pilot Projects",
            "Retrospective Studies",
            "Adult",
            "Genetic Counseling",
            "Prenatal Diagnosis",
            "Ultrasonography, Prenatal"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40789765/",
        "source_type": "Global"
    },
    {
        "pmid": "40787612",
        "title": "Micronutrient and protein-energy supplementation enhance vaccine responses in undernourished children: Evidence from a systematic review.",
        "abstract": "Malnutrition impairs immune function vaccine responses particularly lowincome settings lead reduced seroconversion rate compromised herd immunity children Nutritional intervention proposed enhance vaccine immunogenicity yet evidence remains scattered context specific systematic review assesses impact nutritional interventionsespecially vitamin A zinc supplementation proteinenergy rehabilitationon serological response routine childhood vaccine among malnourished child low middleincome countries Following PRISMA guidelines searched PubMed Embase Cochrane Library Global Health Library study published 2000 2024 Eligible study included randomized trials cohort studies systematic review reporting nutritional supplementation vaccine seroconversion outcome malnourished children 3245 records 42 study met inclusion criteria Vitamin supplementation improved measles vaccine seroconversion 35 especially among deficient children Zinc enhanced response oral vaccine 20 Proteinenergy rehabilitation significantly increased seroconversion rate BCG measles vaccines particularly child recovering severe acute malnutrition Nutritional intervention improve vaccine immunogenicity among malnourished children Integrated strategy combining immunization nutrition service prioritized address immunity gap vulnerable populations",
        "mesh_terms": [
            "Humans",
            "Dietary Supplements",
            "Micronutrients",
            "Child",
            "Vitamin A",
            "Malnutrition",
            "Zinc",
            "Child Nutrition Disorders",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40787612/",
        "source_type": "Global"
    },
    {
        "pmid": "40784905",
        "title": "SARS-CoV-2 seroprevalence and COVID-19 vaccination coverage in two states of Nigeria from a population based household survey.",
        "abstract": "SARSCoV2 populationbased seroprevalence survey useful estimating extent SARSCoV2 infections may underestimated COVID19 case counts Surveys conducted October 2020 four Nigerian state showed SARSCoV2 seroprevalence ranged 93 Gombe northeast 252 Enugu southeast first COVID19 wave 100 700 time higher official number COVID19 case two states respectively conducted serosurvey second COVID19 wave evaluate extent SARSCoV2 infections attitude COVID19 vaccines COVID19 vaccination coverage two region Nigeria Using World Health Organization WHO Unity protocol 34 enumeration area EAs Federal Capital Territory FCT Northcentral Zone Kano State Northwest Zone sampled June 2021 using probability proportional estimated size 20 household one EA randomly selected consenting assenting member household asked risk behaviors adult 18 year the eligible population COVID19 vaccination Nigeria responded question COVID19 vaccine attitude receipt Blood nasaloropharyngeal sample taken consenting assenting household members Blood sample collected tested Luminex xMAP® SARSCoV2 MultiAntigen IgG Assay swab reversetranscriptasePCR RTPCR Overall response rate 768 FCT n  1505 blood draws 804 Kano State n  2178 blood draws Following second COVID19 wave Nigeria 40 resident FCT 403 95 CI 347459 Kano State 426 95 CI 394458 evidence prior SARSCoV2 infection active SARSCoV2 infection detected RTPCR either FCT Kano State FCT Kano State 34 16 people surveyed reported receipt COVID19 vaccine three month vaccine available country FCT 775 adult aware COVID19 vaccines 469 reported willingness receive them Kano State 487 adult aware COVID19 vaccines 611 willing receive them regions 84 reporting unwillingness accept COVID19 vaccine cited concern vaccine safety Serosurvey finding revealed SARSCoV2 infection far widespread Federal Capital Territory Kano State indicated reported case numbers Despite high awareness COVID19 vaccine uptake remained low primarily due concern vaccine safety result highlight urgent need targeted risk communication address vaccine hesitancy improve coverage Serosurveys provide valuable insight guide public health intervention future pandemic preparedness Nigeria",
        "mesh_terms": [
            "Humans",
            "Nigeria",
            "COVID-19",
            "Seroepidemiologic Studies",
            "Adult",
            "SARS-CoV-2",
            "Female",
            "Male",
            "COVID-19 Vaccines",
            "Middle Aged",
            "Vaccination Coverage",
            "Adolescent",
            "Young Adult",
            "Aged",
            "Surveys and Questionnaires",
            "Family Characteristics",
            "Vaccination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784905/",
        "source_type": "Global"
    },
    {
        "pmid": "40779007",
        "title": "Immunogenicity and safety of the accelerated 2-dose intradermal rabies pre exposure prophylaxis regimen in immunocompetent and immunocompromised pediatric populations: a comparative study.",
        "abstract": "Rabies fatal zoonotic disease India account 35 global rabiesrelated deaths 2018 World Health Organization WHO revised guideline preexposure prophylaxis PrEP 3dose costsaving 2dose intradermal ID regimen study evaluates immunogenicity safety regimen pediatric populations including child exposed immunosuppressant therapy singlecenter prospective comparative followup study conducted tertiary care hospital Participants 518 years enrolled two groups 1 child known immunodeficiency n  31 2 child immunosuppressant therapy n  10 received Vero cell culture rabies vaccine RABIVAXSsup®sup intradermally two site day 0 7 Serum antirabies virus glycoprotein antibody titre assessed day 28 90 180 using ELISAbased assay Booster dos administered insufficient titer ≤ 05 EUml day 28 group achieved 100 seroconversion rate SCR Geometric mean titer GMT 2168 EUml 1547 EUml noknownimmunodeficiency immunosuppressant therapy groups respectively day 90 SCRs 90 70 GMTs 1358 EUml 0962 EUml respectively Booster dos restored titer participant insufficient levels Pain injection site solicited adverse effect 2dose ID PrEP regimen immunogenic safe pediatric populations including immunosuppressed children offer costeffective alternative rabiesendemic regions enhancing compliance accessibility Prospectively registered Clinical Trials Registry India Trial Registration No CTRI202210046777",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40779007/",
        "source_type": "Global"
    },
    {
        "pmid": "40770709",
        "title": "Parental and step-parental attitudes toward childhood vaccination in Kaduna State of Nigeria: a health belief model approach.",
        "abstract": "Childhood vaccination crucial public health intervention prevents spread vaccinepreventable disease reduces childhood morbidity mortality However vaccine hesitancy low immunization rate remain global challenges study aimed explore parents stepparents attitude toward childhood vaccination using Health Belief Model HBM analytical crosssectional survey conducted among 384 parent stepparents 1845 years diverse socioeconomic background Kaduna State Nigeria Participants selected consecutive sampling eligible individual completed questionnaire evaluating attitude toward childhood vaccination Data analyzed using attended Barau Dikko Teaching Hospital BDTH data collection period HBM SPSS version 29 employing descriptive statistic inferential tests including independent ttest OneWay ANOVA pvalue ≤ 005 considered statistically significant Participants perception moderate different dimension health belief HB Perceived susceptibility severity barrier moderate concern level Mean  237 SD  0576 Mean  215 SD  0653 Mean  254 SD  0585 respectively Parents positive attitude towards vaccination benefit Mean  386 SD  0735 moderate cue action Mean  275 SD  0677 health motivation Mean  363 SD  0865 Independent ttests showed gender p  016 residency p  005 associated health belief score However parental status variable substantial association HB score p  001 Oneway ANOVA test found significant association HB score age tribe marital status employment status family income religion p  098 075 005 037 059 060 respectively light findings clear addressing perceived barrier augmenting cue action critical fostering positive parental health behaviors particularly regarding childhood vaccination although study needed confirm results Capitalizing favorable perception vaccination benefit cultivating existing health motivation emerge effective strategy promoting health",
        "mesh_terms": [
            "Humans",
            "Nigeria",
            "Adult",
            "Male",
            "Female",
            "Parents",
            "Cross-Sectional Studies",
            "Middle Aged",
            "Adolescent",
            "Young Adult",
            "Health Belief Model",
            "Health Knowledge, Attitudes, Practice",
            "Vaccination",
            "Surveys and Questionnaires"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770709/",
        "source_type": "Global"
    },
    {
        "pmid": "40770695",
        "title": "The role of religious leaders in the acceptance of COVID-19 vaccinations: a systematic review.",
        "abstract": "development COVID19 vaccine progressing rapidly vaccination acceptance posed many challenge different communities study systematically reviewed impact religious leader acceptance COVID19 vaccinations also examined religious leaders role shaping followers vaccination decision explored strategy religious organization use promote vaccination COVID19 study followed Preferred Reporting Items Systematic Reviews MetaAnalyses PRISMA guidelines primary database used search literature PubMed Web Science WOS Scopus ProQuest ScienceDirect Google Scholar identify relevant published literature title systematic review divided two key components keywords related COVID19 vaccination religious leaders along synonyms review analyzed seven article using content analysis explore diverse role religious leader COVID19 vaccination acceptance analysis identified two key themes positive contribution religious leader promoting vaccination negative neutral roles highlighting differing perspective influence pandemic Engaging religious leader disseminating adopting national global health initiatives capacity building training trust building collaboration health providers dialogue community COVID19 vaccination program powerful strategy advance World Health Organization WHO goals",
        "mesh_terms": [
            "Humans",
            "COVID-19 Vaccines",
            "COVID-19",
            "Leadership",
            "Vaccination Hesitancy",
            "Patient Acceptance of Health Care",
            "Vaccination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770695/",
        "source_type": "Global"
    },
    {
        "pmid": "40770596",
        "title": "Influenza vaccination uptake of health care workers in a tertiary hospital: Findings from qualitative research in Mysuru, India.",
        "abstract": "Vaccinating health care worker HCWs common way prevent influenzarelated infection transmission patient absenteeism HCWs India influenza contributes 130000 death per year yet vaccination uptake HCWs low Fifteen percent HCWs received one vaccination 5 years study explored social context influenza vaccine uptake among HCWs including physicians nurse medical student teaching hospital Mysuru South India generate insight inform influenza vaccination campaign targeting HCWs Qualitative methods including indepth interview HCWs structured observation various department hospital applied result indicate influenza vaccination uptake among HCWs low due personal factor related little perceived personal threat emphasis prevention technique avoid transmission cost vaccine needle anxiety Besides institutional factors absence recommendation superior lack promotion campaign contribute low uptake conclusion HCW vaccination education promotion regarding diminishing personal transmission risk influenza virus uniform vaccination guideline strategy improve access including burdened cost vaccine suggested",
        "mesh_terms": [
            "Humans",
            "India",
            "Influenza, Human",
            "Influenza Vaccines",
            "Qualitative Research",
            "Tertiary Care Centers",
            "Female",
            "Male",
            "Adult",
            "Health Personnel",
            "Vaccination",
            "Interviews as Topic",
            "Attitude of Health Personnel",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770596/",
        "source_type": "Global"
    },
    {
        "pmid": "40770333",
        "title": "Evaluation of risk factors for poor wound healing after cesarean delivery in patients with gestational diabetes mellitus: a retrospective study.",
        "abstract": "Poor wound healing PWH significant complication following cesarean deliveries particularly patient gestational diabetes mellitus GDM due hyperglycemiainduced immune dysfunction impaired wound healing Identifying specific risk factor essential developing effective preventive strategy improving maternal outcomes retrospective study conducted January 2020 August 2023 followed STROBE guidelines total 268 GDM patient underwent cesarean delivery included 5 lost followup yielding 982 followup rate Patients divided two groups PWH group n  26 control group n  242 Comprehensive data maternal age gestational age prepregnancy BMI IVFET use uterine scarring surgery type emergency vs elective operative time infection Candida albicans Group B Streptococcus collected Statistical analysis included Chisquare Fishers exact tests multivariate logistic regression identify independent risk factor PWH overall incidence PWH 97 majority superficial infections including suture reaction 385 bleeding exudation 308 abscess 154 fat liquefaction 115 Deep infection rare 38 presenting endometritis case pelvic abscess Multivariate logistic regression identified following significant independent risk factor PWH premature rupture membrane OR  1088 95 CI 1707125 P  0002 Candida infection OR  577 95 CI 1891865 P  0003 emergency cesarean delivery OR  232 95 CI 102548 P  0047 scarred uterus OR  368 95 CI 143939 P  0006 prolonged operative time ≥ 1 h  255 95 CI 102373 P  0031 Prolonged operative time premature rupture membrane PROM emergency cesarean delivery uterine scarring identified independent risk factor PWH GDM patients Candida infection also showed statistical association based limited case number interpreted cautiously Targeted perioperative strategy may help reduce PWH risk population",
        "mesh_terms": [
            "Humans",
            "Female",
            "Retrospective Studies",
            "Pregnancy",
            "Cesarean Section",
            "Diabetes, Gestational",
            "Adult",
            "Risk Factors",
            "Wound Healing",
            "Postoperative Complications",
            "Surgical Wound Infection"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770333/",
        "source_type": "Global"
    },
    {
        "pmid": "40765649",
        "title": "Cyclic Thrombocytopenia Treated With Platelet Transfusion and Oral Preparation Containing Hyaluronic Acid (Oralvisc).",
        "abstract": "Cyclic thrombocytopenia CTP rare disorder characterized periodic platelet fluctuation substantial amplitude low high Currently standardized guideline treatment patient CTP generally respond standard ITP treatments including corticosteroids splenectomy intravenous immunoglobulin present case chronic CTP failed multiple therapy used immune thrombocytopenia resolution mucocutaneous bleeding supportive platelet transfusion platelet nadir Eventually patient normalization platelet count applied oral preparation containing hyaluronic acid Oralvisc concomitant osteoarthritis effect Oralvisc platelet count retained discontinuation drug suggest supportive platelet transfusion nadir thrombocytopenia effective management option symptomatic patients Antiinflammatory medications suppressing bradykinin leptin may applied alleviate platelet fluctuation improve symptoms",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40765649/",
        "source_type": "Global"
    },
    {
        "pmid": "40765002",
        "title": "Neisseria Meningitidis Carriage Among Hajj and Umrah Pilgrims: A Systematic Review and Meta-Analysis.",
        "abstract": "Meningococcal meningitis MM caused bacterium Neisseria meningitidis represents considerable public health concern Hajj Umrah pilgrimages mass gathering close quarter associated event create environment enhances transmission potentially lifethreatening infection Despite mandatory vaccination policies concern persist regarding carriage rate potential outbreaks heightened several factors systematic review singlearm metaanalysis aimed evaluate carriage Neisseria meningitidis NM vaccination status among pilgrims systematic review metaanalysis conducted according PRISMA guidelines focusing Muslim pilgrim nationality participated mass gathering Hajj Umrah Makkah Saudi Arabia performed comprehensive search four electronic database PubMed Scopus Web Science Cochrane Central Register Controlled Trials inception April 2024 Eligible study reported N meningitidis carriage prevalence serogroups vaccination status among Hajj Umrah pilgrims primary outcome measured overall carriage prevalence Neisseria meningitidis determined time assessment Data synthesized using randomeffects models 417 study initially screened 21 study 23552 participants included systematic review metaanalysis consisted nine studies carriage prevalence NM Hajj 16 increasing 34 Hajj Prior Hajj estimate serogroup W recorded 0003 95 CI 0001 0006 0068 95 CI 014 015 respectively Following Hajj estimate shifted 0001 95 CI 0000 0002 serogroup 0072 95 CI 0037 0108 serogroup W Vaccination status varied gap among domestic pilgrims along presence ciprofloxacin resistance certain strains Saudi Arabias commendable sustained commitment proactive prevention strategy Hajj Umrah reduced Neisseria meningitis cases Nonetheless carriage variability rising antimicrobial resistance Neisseria meningitidis highlight need enhanced surveillance alternative prophylaxis strategy highrisk populations finding study remain inconclusive due significant heterogeneity underscore need comprehensive wellstructured primary study gather strong evidence",
        "mesh_terms": [
            "Humans",
            "Neisseria meningitidis",
            "Saudi Arabia",
            "Islam",
            "Meningitis, Meningococcal",
            "Carrier State",
            "Mass Gatherings",
            "Meningococcal Vaccines",
            "Prevalence",
            "Meningococcal Infections",
            "Crowding"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40765002/",
        "source_type": "Global"
    },
    {
        "pmid": "40764930",
        "title": "Repair of infarcted myocardium by skeletal muscle-derived mesenchymal stromal cells delivered by a bioprinted collagen patch.",
        "abstract": "Mesenchymal stromal cell MSC commonly investigated postinfarction cardiac repair angiogenic antiinflammatory immunomodulatory properties However autologous source bone marrow adipose tissue require substantially invasive harvest procedure allogeneic MSC cord raise issue batch batch variability study assessed effect another underinvestigated cell source skeletal muscle whose autologous MSC feature clinically appealing advantage retrievable minimally invasive microbiopsy MSC differentiated induced pluripotent stem cell iPSC selected control also look clinically attractive high scalability high degree reproducibility vitro musclederived md MSC exhibited typical MSC feature including trilineage differentiation potential robust angiogenic antiinflammatory antifibrotic immunemodulatory effects Overall outperformed iPSCMSC raised safety concern linked persistence pluripotencyassociated markers thus chosen subsequent vivo evaluation rat model left ventricular LV dysfunction induced ischemiareperfusion end mdMSC embedded collagen bioprinted gel resulting epicardiallydelivered patch significantly improved LV ejection fraction compared cellfree patch shamoperated controls Transcriptomic analysis revealed benefit accompanied downregulation fibrosis apoptosis inflammationrelated genes exploratory proofofconcept study thus suggests mdMSC offer attractive alternative combine autologous origin minimally invasive harvest procedure Bioprinting cell collagen bioink allows generate patch endowed cardioreparative properties",
        "mesh_terms": [
            "Mesenchymal Stem Cells",
            "Myocardial Infarction",
            "Animals",
            "Mesenchymal Stem Cell Transplantation",
            "Rats",
            "Collagen",
            "Cell Differentiation",
            "Muscle, Skeletal",
            "Induced Pluripotent Stem Cells",
            "Male",
            "Bioprinting",
            "Humans",
            "Myocardium"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764930/",
        "source_type": "Global"
    },
    {
        "pmid": "40764083",
        "title": "Association between initial lipid and lipoprotein levels, oxidative stress indicators and clinical efficacy of intravenous methylprednisolone in moderate-to-severe thyroid-associated ophthalmopathy: protocol for a real-world prospective cohort study.",
        "abstract": "Thyroidassociated ophthalmopathy TAO common orbital disease adults autoimmune disease orbital periorbital tissues Typical ocular symptom TAO include periorbital oedema conjunctival congestion oedema eyelid retraction exophthalmos restrictive strabismus etc Hypercholesterolaemia considered one modifiable risk factor TAO However unclear whether lipid level related TAO activity severity intravenous glucocorticoid GC therapeutic effect study aim evaluate association initial lipid lipoprotein levels clinical feature TAO efficacy intravenous methylprednisolone patient moderatetosevere TAO well explore oxidative stressrelated mechanism involved realworld prospective cohort study recruit 178 patient moderatetosevere TAO receive two intravenous methylprednisolone regimens respectively primary outcome improvement composite index 3 month baseline treatment secondary outcome including ocular features change serological characteristic major adverse events study protocol approved ethic committee Xiangya Third Hospital Central South University Kuai241012 29 November 2024 study conducted according guideline Declaration Helsinki Participants informed purpose content study complete written informed consent form recruited finding published peerreviewed journal well report relevant conferences Chinese Clinical Trial Registry ChiCTR2400094094 Registered 17 December 2024",
        "mesh_terms": [
            "Humans",
            "Graves Ophthalmopathy",
            "Methylprednisolone",
            "Prospective Studies",
            "Oxidative Stress",
            "Glucocorticoids",
            "Lipids",
            "Lipoproteins",
            "Adult",
            "Administration, Intravenous",
            "Treatment Outcome",
            "Severity of Illness Index",
            "Female",
            "Male",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764083/",
        "source_type": "Global"
    },
    {
        "pmid": "40763975",
        "title": "[Analysis of a child with Congenital leukemia and mosaicism trisomy 21 syndrome without GATA1 gene mutation].",
        "abstract": "explore genetic characteristic pathogenesis child mosaicism trisomy 21 Congenital leukemia CL child admitted Ningbo Women Childrens Hospital March 2023 selected study subject retrospective analysis carried clinical data laboratory test results immunophenotyping genetic characteristic child study approved Medical Ethics Committee Hospital Ethics No EC2024063 Whole genome sequencing WGS revealed child mosaicism trisomy chromosome 21 ratio approximately 74 addition copy number variation involving multiple OMIM gene could explain clinical phenotype detected rated pathogenic based guideline American College Medical Genetics Genomics ACMG pathogenic variant detected GATA1 gene Blood immune typing child conformed immunophenotype acute myeloid leukemia child trisomy 21 even absence GATA1 gene variants occurrence CL monitored early diagnosis treatment great significance improving prognosis",
        "mesh_terms": [
            "Child, Preschool",
            "Humans",
            "DNA Copy Number Variations",
            "Down Syndrome",
            "GATA1 Transcription Factor",
            "Leukemia",
            "Mosaicism",
            "Mutation",
            "Retrospective Studies",
            "Whole Genome Sequencing"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40763975/",
        "source_type": "Global"
    },
    {
        "pmid": "40760409",
        "title": "Determining population-specific risk factors for COVID-19 susceptibility and severity to inform future individual-level integrated risk scoring.",
        "abstract": "Acute respiratory tract infection ARI including COVID19 significant global health challenge pandemic potential Understanding factor influencing ARI susceptibility severity different population crucial pandemic preparedness mitigation investigated epidemiological risk factor COVID19 susceptibility severity Israeli population Participants took COVID19 PCR test July 2021 August 2022 completed online survey including demographics comorbidities infection vaccination status identified factor associated SARSCoV2 infection disease severity using logistic regression compared result global literature included 2128 participants 823 participant tested positive SARSCoV2 Individuals without COPD BMI  30 higher infection odds aOR  621 95 CI1422725 aOR  154 95 CI102232 respectively High schoollevel education associated increased susceptibility severity compared higher education aOR  155 95 CI11218 aOR  280 95 CI 162486 respectively Hospitalization associated older age p  0001 Vaccination 3 dos significantly reduced infection hospitalization risk compared unvaccinated aOR  0024 95 CI0016004 aOR  037 95 CI 017081 respectively p  005 Compared Arab participants Jewish one less likely infected aOR  148 95 CI102215 p  005 Identified risk factor consistent metaanalyses study countries Similar countries minority group found higher risk therefore risk model predicting ARI susceptibility severity take account",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Male",
            "Female",
            "Middle Aged",
            "Risk Factors",
            "Israel",
            "Adult",
            "Aged",
            "SARS-CoV-2",
            "Severity of Illness Index",
            "Disease Susceptibility",
            "Young Adult",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760409/",
        "source_type": "Global"
    },
    {
        "pmid": "40760155",
        "title": "Network epidemiological analysis of COVID-19 transmission patterns by age, occupation and residence across four waves in Cyprus.",
        "abstract": "Complex transmission pattern immediately obvious epidemiologists hindering development effective intervention strategies aim develop networkbased tool identify transmission pattern across agegroups occupations locations Infection network constructed using COVID19 contact tracing data provided Cyprus Ministry Health March 2020 May 2021 Transmission pattern withinacross agegroups districts economic activities well presence superspreaders vulnerability different groups assessed using constructed network first four pandemic waves constructed network wave sparse Network analysis showed first wave primarily involved older individual healthcare settings second wave higher infection rate among young adult observed dominant transmission pattern third fourth wave existed i individual similar ages commonly interact ii individual age difference  30 year ie generational gap Crossdistrict pattern revealed transmission likely occur district nearest geographically also followed social trends Furthermore study identified vulnerable occupations Outdegree representing number secondary infection caused individual also investigated pandemic progressed decreased outdegree among older age group 50  likely reflected positive effect vaccination immunity contrast rising value among younger individual probably reflected fewer vaccination active social interactions Age district occupation pattern transmission superspreader concentration guide targeted intervention strategies prioritize vaccination efforts support decisionmaking effective control prevention pandemics",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Cyprus",
            "Adult",
            "Middle Aged",
            "Contact Tracing",
            "Young Adult",
            "Occupations",
            "Male",
            "Adolescent",
            "SARS-CoV-2",
            "Female",
            "Age Factors",
            "Aged",
            "Child",
            "Pandemics",
            "Child, Preschool",
            "Infant"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760155/",
        "source_type": "Global"
    },
    {
        "pmid": "40759335",
        "title": "Global Approach for Severe Cutaneous Adverse Reactions (GRASS) Survey.",
        "abstract": "Consensus guideline outline recommended management delayed drug hypersensitivity reaction DHR clinical practice largely expertbased may vary significantly across population regions study evaluated approach management healthcare specialist globally regarding DHR including severe cutaneous adverse reaction SCARs assess current practices knowledge availability allergy testing DHR including SCARs among relevant healthcare professional globally GRASS Global AppRoAch Severe Cutaneous Adverse Reactions Survey study prospective webbased survey conducted using Research Electronic Data Capture REDCap platform 10 15minute survey directed 14 allergyimmunology dermatology association international mailing list across 48 countries Among 8561 member contacted answer 130 healthcare provider practicing six continent analyzed respondent identified Caucasian 88130 68 female 79130 61 representing range age group clinical expertise practiced dermatology 69130 53 followed allergyimmunology 46130 354 based urban setting 127130 98 Among 45 respondent 346 managed SCARs 27 60 access multidisciplinary care Practices varied widely clinical phenotype example maculopapular exanthema 63 respondent indicated treating reaction 63130 49 16 1613012 offered desensitization patient education followup 60 60130 462 participant organized followup implicated specialist Significant variability management DHR observed among respondents result highlight need evidencebased protocol standardize guideline managing DHRs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40759335/",
        "source_type": "Global"
    },
    {
        "pmid": "40755993",
        "title": "How Do Polymorphonuclear Counts in Ascitic Fluid Correlate to Hospital Outcome.",
        "abstract": "Polymorphonuclear neutrophil PMNs critical mediator innate immune response level ascitic fluid pivotal diagnosing spontaneous bacterial peritonitis SBP particularly patient liver cirrhosis retrospective study investigates association varying PMN count ascitic fluid hospital outcomes including mortality 30day readmission rates length stay LOS analyzed deidentified data HCA Healthcare hospital July 2013December 2023 focusing patient aged 18 older diagnosis liver cirrhosis underwent paracentesis Patients categorized based PMN count three grouping assess clinical outcomes finding suggest lower PMN count correlate increased mortality particularly group count ≤100 ≤200 cellsmmsup3sup Conversely higher PMN count 201249 cellsmmsup3sup associated reduced odds mortality 30day readmission demonstrated complex associations higher count also linked increased readmission risk highest subgroup Interestingly LOS showed significant difference across PMN levels study underscore nuanced role PMN count prognostication treatment decision cirrhotic patients Given emerging literature questioning strict PMN diagnostic threshold SBP result advocate reconsideration current guideline optimize patient management outcomes investigation warranted delineate implication PMN level context antimicrobial therapy broader clinical strategy liver disease management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755993/",
        "source_type": "Global"
    },
    {
        "pmid": "40755013",
        "title": "The contribution of minimally invasive tissue sampling compared to antemortem-derived cause of death determination among inpatient child deaths: the minimally invasive tissue sampling in Malawi study.",
        "abstract": "Improved cause death CoD understanding low middleincome country needed reduce child mortality Compared full autopsy minimally invasive tissue sampling MITS using transcutaneous needle sampling feasible socially acceptable validated method aimed quantify additional contribution MITS CoD attribution based clinical record inpatient research data intensive patient characterisation enrolled child aged seven day 59 month died admission acute illness andor severe malnutrition Queen Elizabeth Central Hospital Blantyre Malawi Standard MITS procedure included histologic immunohistochemical microbiologic testing Phase 1 CoD determination based medical record alone Phase 2 also included research data Phase 3 included data including MITS enrolled 29 children Based clinical note alone Phase 1 identified 60 causal 39 contributing conditions 45 45 infectious conditions pathogen identified 15 33 one patients 3 CoD unchanged compared including data Phase 3 Further identified 69 new n  43 adjusted n  26 diagnosis among 28 case 97 majority undernutritionrelated n  22 32 infectious n  41 59 conditions Overall majority final Phase 3 condition also undernutritionrelated n  46 32 infectious n  61 43 pathogen identified 54 89 infectious conditions Klebsiella pneumoniae prevalent aetiology pneumonia sepsis addition MITS clinical inpatient research data led almost 97 case receiving new andor refined diagnoses including microbe identification infectious conditions Pathogens specifically addressed current clinical guidelines Klebisiella pneumoniae commonly identified finding support utility MITS understand CoD even thorough clinical characterisation child hospitalisation",
        "mesh_terms": [
            "Humans",
            "Malawi",
            "Infant",
            "Male",
            "Female",
            "Child, Preschool",
            "Cause of Death",
            "Infant, Newborn",
            "Autopsy",
            "Child Mortality",
            "Specimen Handling",
            "Inpatients"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755013/",
        "source_type": "Global"
    },
    {
        "pmid": "40751830",
        "title": "Treatment of refractory non-small cell lung cancer with combined infusion of modified CIK cells and PD1 antibody: safety and efficacy.",
        "abstract": "evaluate safety efficacy modified CIK cell combined PD1 antibody treatment refractory nonsmall cell lung cancer NSCLC Fifteen patient refractory NSCLC treated hospital recruited clinical study January 2015 December 2020 patient disease progression completing routine treatment Two 12 patient achieved partial remission 6 stable disease 4 progressive disease serious side effect occurred percentage helper NKTlike cell patient increased significantly immunotherapy P  005 addition antitumor cytokine IL2 INFγ increased significantly P  005 Although antiinflammatory cytokine IL10 change markedly immunotherapy P  005 Karnofsky Performance Scale improved Umbilical cord blood mononuclear cell induced NKTlike cells Induced NKTlike cell powerful cytotoxicity tumor cell line vitro combined PD1 antibody Immunotherapy also significant therapeutic effect refractory NSCLC serious side effect vivo",
        "mesh_terms": [
            "Humans",
            "Carcinoma, Non-Small-Cell Lung",
            "Male",
            "Female",
            "Lung Neoplasms",
            "Middle Aged",
            "Cytokine-Induced Killer Cells",
            "Programmed Cell Death 1 Receptor",
            "Aged",
            "Treatment Outcome",
            "Adult",
            "Cell Line, Tumor",
            "Immunotherapy, Adoptive"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40751830/",
        "source_type": "Global"
    },
    {
        "pmid": "40750869",
        "title": "Association between the systemic immune-inflammation index and anemia among US children: national health and nutrition examination survey (NHANES), 2001-2018.",
        "abstract": "study aimed investigate correlation Systemic immuneinflammation index SII anemia prevalence children study employed crosssectional design analyzing data 8157 participant aged less 18 years SII calculated platelet count×neutrophil countlymphocyte count Anemia defined using World Health Organization WHO guideline based normal hemoglobin HGB value different age genders Logistic regression analyses subgroup analysis sensitivity analysis performed investigate relationship SII anemia study included total 8157patients 409 50 anemia multivariate logistic regression analysis showed higher level SII associated higher risk developing anemia OR  169 95 CI 127225 p  001 relationship SII anemia followed linear patternpvalue nonlinearity005 Subgroup analysis showed significant dependence gender race family size Povertyincome ratio PIR asthma diabetes vitamin except age positive association Furthermore sensitivity analysis confirmed robustness results finding indicate SII level positively linked anemia children Monitoring SII level may facilitate early identification highrisk pediatric anemia groups enabling targeted interventions SII could costeffective simple anemia identification tool though need confirmation via prospective studies approach hold potential enhancing public health policy child health management",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Cross-Sectional Studies",
            "Anemia",
            "Child",
            "Inflammation",
            "Child, Preschool",
            "Nutrition Surveys",
            "United States",
            "Adolescent",
            "Prevalence",
            "Infant",
            "Platelet Count"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750869/",
        "source_type": "Global"
    },
    {
        "pmid": "40750850",
        "title": "Antimicrobial prescribing patterns among pediatric outpatient encounters in primary healthcare centers in Bujumbura Mairie, Burundi.",
        "abstract": "Understanding prescribing pattern essential developing targeted intervention promote rational antimicrobial use study evaluated antimicrobial prescribing pattern among pediatric outpatient primary healthcare center PHCs Bujumbura Mairie republic Burundi conducted crosssectional study 20 PHCs Bujumbura Mairie Republic Burundi evaluate antimicrobial prescribing patterns collected retrospectively 2022year data medical record using World Health OrganizationInternational Network Rational Use Drugs WHOINRUD core drug indicators According guidelines minimum sample size 600 prescription recommended assess drug use indicators meet requirement total 800 paediatric outpatient prescription sampled Prescriptions inpatient excluded total 497 621 800 prescription contained antimicrobials far exceeding recommendation 20268 Younger patients particularly child five received highest proportion antimicrobial prescription 156 Although generic prescribing 950 adherence National Essential Medicine Lists NEML 958 high fell short benchmark 100 prescription followed monotherapy 928 low average 11 antimicrobial per prescription WHO guideline 1618 Although Accessgroup dominated 713 Watchgroup usage 253 surpassed recommended threshold  20 nonrecommended fixeddose combination also prescribed 34 addition 262 prescription lacked documented indications present study highlight strong adherence essential medicine list generic antimicrobial use However finding also reveal area improvement including need documentation indication reduction utilization Watch group antibiotic use optimize antimicrobial use prevent AMR Burundis paediatric population national research healthcare worker training diagnostics antimicrobial stewardship implementation necessary",
        "mesh_terms": [
            "Humans",
            "Burundi",
            "Cross-Sectional Studies",
            "Child, Preschool",
            "Child",
            "Primary Health Care",
            "Practice Patterns, Physicians'",
            "Infant",
            "Male",
            "Female",
            "Retrospective Studies",
            "Anti-Infective Agents",
            "Adolescent",
            "Drug Prescriptions",
            "Infant, Newborn",
            "Anti-Bacterial Agents"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750850/",
        "source_type": "Global"
    },
    {
        "pmid": "40750724",
        "title": "Role of Antidrug Antibodies in Oncolytic Viral Therapy: A Dynamic Modelling Approach in Cancer Patients Treated with V937 Alone or in Combination.",
        "abstract": "Oncolytic virus OVs growing immunooncology therapeutic class rely capability activate dormant endogenous antitumor immune response order control eradicate tumor cells Given intrinsic mechanism action biological nature development antidrug antibody ADA represents important aspect consider clinical evaluation ADAs potentially affect viral kinetics andor dynamics ultimately resulting reduction even loss drug efficacy Here present semimechanistic pharmacokineticpharmacodynamic model characterizing interplay V937 neutralizing ADA cancer patient receiving V937 oncolytic virus quantitative framework developed integrating viral load ADA titer 208 cancer patient received V937 following intratumoral intravascular administration monotherapy combination pembrolizumab model successfully captured V937 time course dynamic ADAs different settings showing meaningful impact ADAs viral kinetics Moreover tumor response neither affected preexistence development ADAs explained primary role immune system response quantitative semi mechanistic framework expanded oncolytic virus used explore scenario relevant impact could observed thus supporting development novel oncolytic viral therapies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750724/",
        "source_type": "Global"
    },
    {
        "pmid": "40750284",
        "title": "Towards novel BIOmarkers to diagnose SEPsis (BIOSEP) in the emergency room: a protocol for a multicentre, prospective cohort study.",
        "abstract": "international Surviving Sepsis Campaign guideline highlight need recognising sepsis timely accurate manner Early diagnosis treatment sepsis crucial associated reduced mortality early stage sepsis heterogeneous clinical sign difficult interpret often leading missed delayed diagnoses well inappropriate late use antibiotics urgent need quickly accurately identify patient potential infection emergency department ED risk progressing along infectionsepsis spectrum study aim compare immune response ED patient presenting suspected infection without sepsis gain insight immune aberration identify novel biomarkers linked increased risk developing sepsis sequelae prospective observational cohort study across three hospital Netherlands conducted Adults presenting ED hospitals suspected infection Modified Early Warning Score 2 higher eligible enrolment aim include 3330 patients main study parameter characterisation host immune metabolic response using multiomics analysis Raman spectroscopy mass spectrometry gut microbiota profiling relation clinical outcome 30day mortality length hospital stay readmission postsepsis sequelae Verbal written informed consent obtained participant legal representatives study approved Amsterdam University Medical Centre Ethics Committee No 20220279 adhere Declaration Helsinki Medical Research Involving Human Subjects Act WMO Research result published peerreviewed journals ClinicalTrialsgov NCT06178822",
        "mesh_terms": [
            "Humans",
            "Biomarkers",
            "Emergency Service, Hospital",
            "Sepsis",
            "Prospective Studies",
            "Netherlands",
            "Multicenter Studies as Topic",
            "Observational Studies as Topic",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750284/",
        "source_type": "Global"
    },
    {
        "pmid": "40748340",
        "title": "Genetic and Clinical Characteristics of Difficult-To-Treat Crohn's Disease: Trio-Based Exome Sequencing in 24 Families.",
        "abstract": "Difficulttotreat Crohns disease DTTCD represents critical unmet need inflammatory bowel disease IBD management However genetic architecture remain poorly understood aimed evaluate genetic characteristic clinical manifestation DTTCD case integrated triobased whole exome sequencing WES longitudinal phenotyping crosssectional cohort study DTTCD patient met International Organization Study Inflammatory Bowel Disease IOIBD criterion firstdegree relative underwent trioWES analysis Treatment persistence remission rate analyzed Genetic variant prioritized via cosegregation analysis American College Medical Genetics Genomics ACMG guidelines functional prediction algorithms Among 24 patient DTTCD 875 failed least two biologics 333 required dual targeted therapy drug persistence declined across treatment line p  00193 Remission rate suboptimal clinical 417 endoscopic 500 TrioWES analysis identified 15 likely pathogenic candidate variant across 12 genes including established monogenic IBD gene XIAP two novel variants pAsp247Glufs19 pSer43X two known variants pArg381X pArg238X genomewide association studiesimplicated IBD risk gene MAML2 PLA2R1 novel candidate variant KIZ LAMA5 SAMD9 etc potentially linked epithelialimmune dysregulation first trioWES study DTTCD reveals high prevalence monogenic XIAP deficiency 167 advocating genetic screening refractory cases Novel candidate gene implicate polygenic mechanism therapeutic resistance Familybased sequencing may used elucidate genetic background DTTCD case guide molecular diagnosis personalized therapy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40748340/",
        "source_type": "Global"
    },
    {
        "pmid": "40746762",
        "title": "The Impact of Holder Pasteurization on Macronutrients, Vitamins, Minerals, and Bioactive Factors in Human Milk Processed in a Milk Bank Setting.",
        "abstract": "Donor human milk recommended nutritionally vulnerable preterm infant however conflicting limited information pasteurization technique used donor milk influence nutritional immune properties Additionally prior pasteurization study often reflective volume equipment used milk bank settings limiting generalizability Evaluate impact Holder pasteurizationperformed milk bank setting using standardized preanalytical handling techniqueson energy macronutrients human milk oligosaccharides vitamins minerals antimicrobial protein content human milk Fifty matched pair raw Holderpasteurized milk sample collected pasteurized milk bank setting provided sampling frame pair unique approved milk bank donor Mothers Milk Bank North Texas total 29 nutrient bioactive factor assessed using variety analytical methods evidence minimal loss 15 copper calcium thiamine nonprotein nitrogen moderate loss immunoglobin concentration 35 extensive loss lactoferrin 80 Holder pasteurization minimal impact energy essential nutrient donor milk including macronutrients human milk oligosaccharides B vitamins minerals Moderate extensive loss antimicrobial protein warrant research alternative preservation techniques",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40746762/",
        "source_type": "Global"
    },
    {
        "pmid": "40745944",
        "title": "HPV vaccine reporting in Taiwan: media and politics, 2005-2018.",
        "abstract": "study analyzes medium coverage HPV vaccine Taiwan 2005 2018 focus adherence World Health Organization WHO medium guideline influence election cycle reporting patterns content analysis 911 article four major newspaper revealed peak 2008 2014 2018 election years coinciding vaccine policy rollouts article 78 percent appeared national news sections medical professional cited 363 percent cases Coverage primarily emphasized vaccine policy 363 percent health education 364 percent 83 percent article portraying HPV vaccination positively 88 percent explicitly endorsing it However 42 percent adhered WHOs medium communication guidelines headline often misaligned article content finding highlight medias advocacy role key political public health events underscoring need improved journalistic practice ensure accurate guidelineconsistent vaccine communication",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40745944/",
        "source_type": "Global"
    },
    {
        "pmid": "40745336",
        "title": "Investigating the link between HPV genotypes and cervical abnormality incidence in women with HPV infections: insights from a leading referral centre.",
        "abstract": "Cervical cancer CC serious health issue especially low middleincome countries primarily caused human papillomavirus HPV infection particularly genotype 16 18 risk factor include smoking early sexual activity longterm oral contraceptive use Early detection cervical cytology HPV testing vital effective prevention study aimed analyze clinical epidemiological characteristic cervical intraepithelial neoplasia CIN HPVpositive woman Tehran teaching hospital focusing HPV genotype association CIN conducted crosssectional study HPVpositive woman underwent Pap smear testing HPV genotyping via realtime PCR colposcopy biopsy suspected lesions Risk factor like smoking alcohol consumption evaluated statistical analysis performed including ordinal logistic regression Among participants 524 abnormal CIN CIN 311 CIN II 114 CIN III 100 HPV16 prevalent genotype 437 significantly associated severe CIN outcome odds ratio OR  288 95 CI followed HPV18 OR  187 95 CI Smoking increased risk severe CIN OR  153 95 CI older age later age sexual debut correlated better CIN outcomes HPV16 smoking major predictor severe CIN highlighting need targeted intervention HPV vaccination smoking cessation along regular screening lower cervical cancer risks Additional research required evaluate persistence different HPV genotype progression CIN cervical cancer",
        "mesh_terms": [
            "Humans",
            "Female",
            "Papillomavirus Infections",
            "Cross-Sectional Studies",
            "Adult",
            "Genotype",
            "Middle Aged",
            "Uterine Cervical Neoplasms",
            "Uterine Cervical Dysplasia",
            "Iran",
            "Papillomaviridae",
            "Risk Factors",
            "Young Adult",
            "Incidence",
            "Papanicolaou Test"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40745336/",
        "source_type": "Global"
    },
    {
        "pmid": "40738551",
        "title": "Hepatitis A vaccination coverage in adults with chronic liver disease in primary care in England: a retrospective cohort study.",
        "abstract": "International guideline recommend administration two dos preexposure hepatitis vaccination people chronic liver disease prevent severe complications aimed describe hepatitis vaccination coverage mortality adult chronic liver disease England retrospective cohort study using routinely collected medical record data OxfordRoyal College General Practitioners Research Surveillance Centre RSC primary care sentinel network included people aged 18 year older diagnosed chronic liver disease Jan 1 2012 Dec 31 2022 primary outcome interest hepatitis vaccination Hepatitis vaccination coverage calculated using number vaccinated people chronic liver disease numerator chronic liver disease population RSC dataset denominator compared individual characteristic vaccination status using descriptive statistics used multistate survival model estimate transition probability four states 1 diagnosis chronic liver disease 2 first hepatitis vaccination 3 second hepatitis vaccination 4 death 664 571 individual aged 18 year older chronic liver disease identified RSC sentinel network population 625 079 individual included analysis 625 079 individual chronic liver disease 13 875 2·2 received first hepatitis vaccination 3007 0·4 received second dose 732 5·3 13 875 vaccinated individual died 101 065 16·5 611 204 individual without vaccination died study period Adjusting death competing risk vaccination likely among younger age quintiles hazard ratio 5·46 95 CI 5·135·81 nonsmokers 1·59 1·541·65 resident urban area 1·28 1·211·35 individual higher socioeconomic status 1·06 1·031·10 individual diagnosis metabolic dysfunctionassociated steatotic liver disease MASLD 1·71 1·641·78 Individuals history harmful alcohol use 0·36 0·320·39 type 1 diabetes 0·46 0·360·57 chronic kidney disease 0·63 0·570·70 mental disorder 0·66 0·640·69 less likely vaccinated lowest risk mortality people chronic liver disease infectious autoimmune aetiology people MASLD Hepatitis vaccine uptake among people chronic liver disease England low disparity age location urban v rural socioeconomic status Steps taken reduce inequality vaccine administration GlaxoSmithKlines Investigator Sponsored Studies Program",
        "mesh_terms": [
            "Hepatitis A Vaccines",
            "Vaccination Coverage",
            "End Stage Liver Disease",
            "England",
            "Retrospective Studies",
            "Sentinel Surveillance",
            "Routinely Collected Health Data",
            "Humans",
            "Male",
            "Female",
            "Adolescent",
            "Young Adult",
            "Adult",
            "Middle Aged",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40738551/",
        "source_type": "Global"
    },
    {
        "pmid": "40733752",
        "title": "Circulating Antibody's Role During Post-Exposure Prophylaxis, and Beyond for Rabies: A Review.",
        "abstract": "bBackgroundb Since introduction Pasteurs rabies vaccine 1885 rabies prophylaxis postexposure prophylaxis PEP widely administered globally recommendation World Health Organization WHO However 124 documented case PEP failure reported worldwide 1980 2023 Additionally sporadic medium report China showed occasional PEP failure 2017 2024 Rabies remains serious public health problem 150 country regions bMethodsb review summarize PEP procedure recommended Advisory Committee Immunization Practices ACIP WHO also analyze potential contributing factor PEP failure propose concept circulating antibodies discus role PEP Furthermore summarize key guideline clinical trial design US Food Drug Administration FDA Chinas Center Drug Evaluation CDE well latest development monoclonal antibody cocktail therapies bResultsb Adherence core PEP practices wound cleansing infiltration wound immunoglobulin mAbs administration vaccines broader societal involvement crucial preventing rabies infection cases highrisk exposure immunocompromised individuals provision circulating antibody highdose human rabies immune globulin HRIG mAbs utmost importance preventing PEP failure bConclusionsb Early highconcentration circulating antibody important preventing PEP failure Addressing global issue rabies requires involvement entire society collective effort tackle neglected disease achieve WHOs goal zero 30",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40733752/",
        "source_type": "Global"
    },
    {
        "pmid": "40733652",
        "title": "A Single Dose of Yellow Fever Vaccine Provides Long-Term Immunity in Japanese Travelers.",
        "abstract": "Yellow fever YF acute hemorrhagic zoonotic disease cause severe liver damage renal failure hemorrhagic shock antiviral treatment available thus vaccination critical preventive measure Although World Health Organization WHO revised guideline regarding need booster vaccination YF rationale single vaccination provides sufficient longterm immunogenicity study evaluated longterm immunity Japanese adult received single dose YF vaccine study evaluated longterm persistence immunogenicity Japanese adult vaccinated YF vaccine observational study enrolled Japanese adult received single YF vaccination 5 year previously Blood sample collected confirming eligibility study serum level antiyellow fever virus YFVneutralizing antibody measured using 50 plaque reduction neutralization test PRNTsub50sub 65 participant comprised 35 male 30 females median age vaccination 34 years time YF vaccination registration 5 26 years participant remained seropositive even long time Statistical analysis showed correlation time elapsed since YF vaccination PRNTsub50sub result indicate single dose YF vaccine provides adequate longterm immunity Japanese adult booster vaccination routinely required finding strongly aid development travel medicine guideline optimization vaccination strategy reducing usage medical resource simplifying health requirement travelers",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40733652/",
        "source_type": "Global"
    },
    {
        "pmid": "40731926",
        "title": "The Impact of Yes-Associated Protein 1 (YAP1) Expression Patterns in Locally Advanced Breast Cancer: Associations with Pathological Response and Tumor Features.",
        "abstract": "iBackground Objectivesi Hippo pathway via Yesassociated protein 1 YAP1 regulates cell proliferation apoptosis tissue regeneration Aberrant YAP1 activation linked tumor progression immune evasion various cancers including breast carcinoma despite conflicting evidence prognostic value Preclinical study explored drug targeting YAP1TEAD interactions therapeutic application limited iMaterials Methodsi study included 50 patient locally advanced breast cancer assessed multidisciplinary tumor board underwent neoadjuvant treatment per tumor subtype clinical guidelines Eligibility required pretreatment core biopsy posttreatment surgical resection samples Due absence residual tumor patient achieving complete pathological response posttreatment tissue available analyzable 30 patients YAP1 expression evaluated immunohistochemically nuclear cytoplasmic staining patterns ROC analysis identified cutoff YAP1 expression defining tumor ≥70 nuclear ≥80 cytoplasmic staining iResultsi YAP1 expression significant relationship tumor subtype ipi  0001 frequent HER2positive tumor 556 least frequent luminal tumor 111 YAP1 positivity significantly predicted axillary pathological complete response pCR ipi  001 YAP1positive patients 778 achieved axillary pCR compared 317 YAP1negative patients though YAP1 status breast pCR association insignificant ipi  007 MannWhitney U test indicated higher Ki67 value significantly associated positive YAP1 expression ipi  0028 contrast association ER PR status age tumor size Following treatment statistically significant change YAP1 expression nuclear staining decreasing ipi  0004 cytoplasmic staining increased ipi  0002 YAP1 significantly linked axillary pCR HER2 status Ki67 iConclusionsi Post treatment nuclear YAP1 decreased whereas cytoplasmic expression increased showing localization shift result suggest YAP1 may predict treatment response become future therapeutic target",
        "mesh_terms": [
            "Humans",
            "YAP-Signaling Proteins",
            "Female",
            "Breast Neoplasms",
            "Middle Aged",
            "Adaptor Proteins, Signal Transducing",
            "Transcription Factors",
            "Aged",
            "Adult",
            "Biomarkers, Tumor",
            "Immunohistochemistry"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40731926/",
        "source_type": "Global"
    },
    {
        "pmid": "40731762",
        "title": "Multimodal Preoperative Management of Rectal Cancer: A Review of the Existing Guidelines.",
        "abstract": "Rectal cancer management necessitates rigorous multidisciplinary strategy emphasizing precise staging detailed risk stratification inform optimal therapeutic decisionmaking Obtaining accurate histological diagnosis initiating treatment essential Comprehensive staging integrates clinical evaluation thorough medical history analysis assessment carcinoembryonic antigen CEA levels computed tomography CT imaging abdomen thorax Highresolution pelvic magnetic resonance imaging MRI utilizing dedicated rectal protocols critical identifying recurrence risk delineating precise anatomical relationships Endoscopic ultrasound refines staging accuracy determining tumor infiltration depth earlystage cancers preoperative colonoscopy effectively identifies synchronous colorectal lesions earlystage rectal cancer T1T2 N0 M0 radical surgical resection remains standard care although transanal local excision selectively indicated certain T1N0 tumors contrast locally advanced rectal cancer T3 T4 N characterized microsatellite stability proficient mismatch repair optimally managed total neoadjuvant therapy TNT combine chemoradiotherapy oxaliplatinbased systemic chemotherapy Additionally tumor exhibiting high microsatellite instability mismatch repair deficiency respond favorably immune checkpoint inhibitor ICIs evaluation tumor response following neoadjuvant therapy utilizing MRI endoscopic assessments facilitates individualized treatment planning including nonoperative approach patient confirmed complete clinical response comply rigorous followup Recent advancement molecular characterization targeted therapies immunotherapy highlight significant evolution towards personalized medicine effective integration innovation requires enhanced interdisciplinary collaboration improve patient prognosis quality life",
        "mesh_terms": [
            "Humans",
            "Rectal Neoplasms",
            "Preoperative Care",
            "Neoadjuvant Therapy",
            "Practice Guidelines as Topic",
            "Combined Modality Therapy",
            "Neoplasm Staging",
            "Magnetic Resonance Imaging"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40731762/",
        "source_type": "Global"
    },
    {
        "pmid": "40731336",
        "title": "Clinical and immunological predictors of severe pertussis in children: a nomogram-based prediction model.",
        "abstract": "Despite widespread vaccination pertussis remains significant health concern especially infant young children Severe pertussis lead severe complications specific risk factors particularly immunological markers fully understood retrospective case analysis conducted January December 2023 Department Infection Tianjin Second Peoples Hospital Data collected 249 child pertussis 209 common 40 severe cases met inclusion criteria Clinical immunological parameter compared severe common pertussis groups Lasso regression multivariate logistic regression used identify independent risk factors nomogram prediction model constructed validated Key finding included demographic clinical difference severe common pertussis higher rate pneumonia longer hospital stays delayed vaccination severe group Immunological difference showed child severe pertussis altered level humoral cellular immune markers Risk factor severe pertussis included premature birth incomplete vaccination high white blood cell count altered lymphocyte profiles nomogram prediction model showed excellent performance Cindex 0899 strong discriminatory ability AUC  0899 Decision curve analysis demonstrated substantial clinical utility study highlight clinical immunological marker contribute severe pertussis children nomogram prediction model developed provides reliable tool early identification highrisk children improving clinical decisionmaking potential outcome pertussis management",
        "mesh_terms": [
            "Humans",
            "Whooping Cough",
            "Nomograms",
            "Male",
            "Female",
            "Retrospective Studies",
            "Infant",
            "Child, Preschool",
            "Risk Factors",
            "Severity of Illness Index",
            "Child",
            "Biomarkers"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40731336/",
        "source_type": "Global"
    },
    {
        "pmid": "40730889",
        "title": "Effects of neoadjuvant immunotherapy on hearing in patients with head and neck squamous cell carcinoma.",
        "abstract": "Immune checkpoint blockade ICB commonly used treatment modality cancer growing list oncologic indications Ototoxicity potential immunerelated adverse event ICB treatment risk hearing loss ICB remains unknown retrospective chart review sought identify individual received ICB available audiometric data treatment order identify clinically meaningful change hearing single center institutional chart review examined hearing function data patient underwent audiometry ICB treatment Measures included pure tone thresholds distortion product otoacoustic emission DPOAEs tympanometry word recognition scores Ototoxicity assessed using American SpeechLanguageHearingAssociation ASHA Common Terminology Criteria Adverse Events CTCAEv50 guideline applicable identified twelve individual newly diagnosed advancedstage Head Neck Squamous Cell Carcinoma HNSCC received neoadjuvant ICB clinical trial Eleven twelve 92 patient 8 male 4 female age 4179 years meet criterion hearing threshold changes One patient demonstrated 10 dB shift two consecutive frequency one ear meeting minimum ASHA criterion significant change Speech audiometry tympanometry identified difference speech understanding middle ear function preand posttreatment Variations DPOAE amplitude noted potentially indicating early outer hair cell damage despite stable audiometric thresholds small data set newly diagnosed advancedstage HNSCC appears low incidence significant hearing change following neoadjuvant ICB treatment Larger prospective study longterm followup needed evaluate lateonset ototoxicity Cancer survivor treated neoadjuvant immune checkpoint blockade advancedstage head neck squamous cell carcinoma HNSCC appear low risk acute hearing loss based study significant change hearing threshold observed subtle alteration cochlear outer hair cell function detected suggesting importance longterm monitoring capture potential delayed effect hearing insight help reassure patient immediate ototoxic risk highlighting need continued vigilance hearing assessment followup",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Middle Aged",
            "Adult",
            "Aged",
            "Retrospective Studies",
            "Squamous Cell Carcinoma of Head and Neck",
            "Immunotherapy",
            "Head and Neck Neoplasms",
            "Neoadjuvant Therapy",
            "Hearing Loss",
            "Hearing",
            "Immune Checkpoint Inhibitors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40730889/",
        "source_type": "Global"
    },
    {
        "pmid": "40729527",
        "title": "Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings.",
        "abstract": "panel clinicians subjectmatter experts guideline methodologists convened Alzheimers Association conducted systematic review formulated evidencebased recommendation using bloodbased biomarkers BBMs diagnostic workup suspected Alzheimers disease AD within specialized care settings scope focus individual objective cognitive impairment including mild cognitive impairment MCI dementia undergoing evaluation provider trained experienced memory disorders AD suspected underlying etiology panel conducted systematic review assess diagnostic accuracy BBMs detecting AD pathology BBMs interest included plasma phosphorylatedtau ptau amyloidbeta Aβ test measuring following analytes ptau217 ratio ptau217 nonptau217 ×100 ptau17 ptau181 ptau231 ratio Aβ42 Aβ40 reference standard test included cerebrospinal fluid CSF AD biomarkers amyloid positron emission tomography PET neuropathology panel applied Grading Recommendations Assessment Development Evaluation GRADE approach assess certainty evidence GRADE evidencetodecision EtD Framework develop recommendations key recommendation Clinical Practice Guideline CPG are 1 BBM test ≥90 sensitivity ≥75 specificity used triaging test 2 BBM test ≥90 sensitivity specificity serve substitute amyloid PET imaging CSF AD biomarker testing patient cognitive impairment presenting specialized care memory disorders panel caution user guideline significant variability diagnostic test accuracy many commercially available BBM test meet thresholds especially using single cutoff Additionally test serve substitute comprehensive clinical evaluation healthcare professional used part full diagnostic workup patient cognitive impairment presenting specialized care settings careful consideration pretest probability AD pathology CPG provides performancebased brandagnostic recommendation use BBMs diagnostic workup suspected AD within specialized care settings linking recommendation systematic review associated living updates using robust transparent methodology guideline ensures scientific rigor adaptability sustained relevance evidence evolves Clinicians encouraged stay informed emerging paradigmssuch biomarker combination ratio multithreshold testingthat may refine diagnostic accuracy BBMs field evolves",
        "mesh_terms": [
            "Humans",
            "Alzheimer Disease",
            "Amyloid beta-Peptides",
            "Biomarkers",
            "Cognitive Dysfunction",
            "Practice Guidelines as Topic",
            "tau Proteins",
            "Systematic Reviews as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40729527/",
        "source_type": "Global"
    },
    {
        "pmid": "40722071",
        "title": "HIV/AIDS-related stigma and discrimination among healthcare providers in Western China: a population-based cross-sectional study.",
        "abstract": "persistence Human Immunodeficiency Virus HIV andor Acquired Immune Deficiency Syndrome AIDSrelated stigma discrimination healthcare setting remains critical issue urgently requires attention effectively control HIVAIDS epidemic study aimed evaluate extent HIVAIDSrelated stigma discrimination explore influencing factor among healthcare provider western China order inform decisionmaking regarding reduction stigma discrimination intervention crosssectional study conducted October 2023 July 2024 24646 with response rate 986 healthcare provider completed survey using concise standardized instrument including sociodemographic workrelated characteristics healthcare institutional policy guidelines attitude opinion people living Human Immunodeficiency Virus PLHIV well discriminatory behaviors Multivariate linear regression analysis performed assess influencing factor HIVAIDSrelated stigma discrimination among healthcare providers proportion healthcare provider expressing concern dressing wound drawing blood 651 603 respectively Approximately 40 participant believed PLHIV care infected others multiple sexual partners Healthcare provider experienced secondary stigma discrimination provision service PLHIV direct stigma discrimination PLHIV 671 respondent agreed PLHIV allowed baby wish 7198 indicated institution related policy guideline protect HIVAIDS patient discrimination HIVAIDSrelated discriminatory behavior higher among healthcare provider lower level education training worked private infectious disease hospital hospital inadequate policies provided face face service PLHIV higher level stigmatizing attitude P  005 HIVAIDSrelated stigma discrimination among healthcare provider prevalent western China factor identified study associated higher HIVAIDSrelated stigma discrimination may provide valuable insight mitigating negative associations coordinated multifaceted approach intervention need implemented effectively reduce HIVAIDSrelated stigma discrimination healthcare settings",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "China",
            "Male",
            "Social Stigma",
            "Female",
            "Adult",
            "Health Personnel",
            "HIV Infections",
            "Middle Aged",
            "Attitude of Health Personnel",
            "Surveys and Questionnaires",
            "Acquired Immunodeficiency Syndrome",
            "Young Adult",
            "Social Discrimination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40722071/",
        "source_type": "Global"
    },
    {
        "pmid": "40718704",
        "title": "A systematic review of vedolizumab in treating pediatric ulcerative colitis: efficacy and safety insights.",
        "abstract": "Ulcerative colitis UC pediatric patient often result corticosteroid CS dependency many individual developing resistance conventional treatment antiTNF agents Vedolizumab monoclonal antibody targeting α4β7 integrin shown promise adult populations data efficacy safety child adolescent limited systematic review aim assess effectiveness safety vedolizumab treating UC pediatric patients PRISMA statements guideline followed conducting systematic review December 2024 thorough search carried using keywords associated inflammatory bowel disease IBD vedolizumab pediatric population Cochrane Library EMBASE PubMed Case series child adolescent less 18 year old UC unclassified IBD treated vedolizumab included research Data clinical response mucosal healing corticosteroidfree remission clinical remission adverse event extracted Descriptive statistic used statistical analysis total 14 paper considered current evaluation effectiveness safety vedolizumab Nearly onethird 36 patient UCIBDU experienced clinical remission 6 weeks half patient 14 week 50 48 53 patient 22 weeks respectively Fortyfive percent patient maintained clinical remission 1 year Less 8 UCIBDU patient experienced serious side effects 1534 patient experienced mucosal healing Vedolizumab exhibit promising efficacy favorable safety profile treating pediatric UC sizable portion patient achieving clinical corticosteroidfree remission However due limited sample size lack investigations randomized controlled trial longterm research needed confirm finding develop reliable clinical guideline use child adolescent UC mean even initial finding promising additional better testing required ensure vedolizumab effective safe young patient UC PROSPERO registration number systematic review CRD420250651513",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40718704/",
        "source_type": "Global"
    },
    {
        "pmid": "40718360",
        "title": "Successful Treatment with Secukinumab in a Psoriasis Patient on Hemodialysis.",
        "abstract": "Moderate severe psoriasis reported independent risk factor IgA nephropathy IgAN IgAN characterized episodic microscopic hematuria progress endstage renal disease ESRD Managing therapeutic intervention psoriasis patient requiring dialysis due ESRD present significant challenges present case severe plaque psoriasis patient concurrently diagnosed IgAN dependent hemodialysis past two months condition worsened without identifiable triggers Physical examination revealed generalized scaly plaque scalp trunk extremities resulting Psoriasis Area Severity Index PASI score 192 Laboratory test confirmed endstage renal insufficiency abnormality detected Consequently patient prescribed subcutaneous secukinumab following standard regimen achieved complete resolution symptom eight week treatment experienced recurrence oneyear followup kidneyrelated parameter remained stable secukinumab therapy summarize case report discusses patient severe psoriasis also concurrent IgAN ESRD successfully treated secukinumab reinforces rapid efficacy enduring safety secukinumab managing psoriasis hemodialysisdependent patient IgAN comorbidity Zeno Fratton et al reported interleukin IL17AF inhibitor effectively treat moderatetosevere psoriasis patient chronic kidney disease CKD However study necessary develop evidencebased guideline biologic selection within vulnerable population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40718360/",
        "source_type": "Global"
    },
    {
        "pmid": "40714729",
        "title": "Post COVID 19 resurgence of diphtheria in Kano, Nigeria: analysis of 18,320 cases.",
        "abstract": "COVID 19 pandemic led significant disruption health services including immunisation programs contributed major postpandemic diphtheria outbreak Kano State Nigeria region accounted 85 nations documented diphtheria cases study examined epidemiology clinical characteristics mortality outcome case diagnosed February 2022 April 2024 Data collected Surveillance Outbreak Response Management Analysis System SORMAS case definition followed guidelines Case fatality rate CFR calculated logistic regression model used assess mortalityrelated risk factors reporting adjusted odds ratio AOR total 18320 case analysed outbreak showing bimodal distribution primary peak occurred August 2023 followed smaller secondary peak early 2024 case fatality rate CFR 45 Patients vaccinated double likelihood death compared fully vaccinated individual AOR 245 95 CI 205 294 p  00001 logistic regression Similarly patient without vaccination documentation also greater odds 87 increase likelihood mortality compared fully vaccinated individual AOR 187 95 CI 127 268 p  00001 logistic regression study reinforces previous report weakening preventive health delivery system resource constrained settings particularly disruption caused COVID 19 pandemic leading resurgence vaccine preventable diseases diphtheria highlight need improved vaccination coverage surveillance systems research receive external funding",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40714729/",
        "source_type": "Global"
    },
    {
        "pmid": "40714362",
        "title": "Short CIAFU recommendations on the screening and management of asymptomatic bacteriuria in immunocompromised patients.",
        "abstract": "Immunosuppression refers functional quantitative reduction immune defenses resulting diminished ability combat microbial pathogens Immunocompromised patient increased risk severe infections associated elevated morbidity mortality routine clinical practice urine culture often performed systematically patient considered risk infection regardless urinary symptoms aim detecting subsequently treating potential asymptomatic bacteriuria study aimed assess clinical relevance screening potentially treating asymptomatic bacteriuria immunocompromised individuals comprehensive literature search conducted using PubMed Medline without restriction language year publication complemented exploration scientific grey literature including expert report guideline professional societies Studies selected using following keywords antibiotic treatment urinary tract infection asymptomatic bacteriuria bacteriuria pyelonephritis cystitis immunodeficiency diabetes renal transplant neurogenic bladder cirrhosis pregnancy antimicrobial resistance abstract fulltext article reviewed synthesis finding subsequently evaluated member CIAFU expert committee formulated consensual recommendation possible Across reviewed literature clear benefit identified screening treating asymptomatic bacteriuria immunocompromised patients recommended screen treat asymptomatic bacteriuria immunocompromised patients except specific wellestablished scenarios Treating asymptomatic bacteriuria reduce infection risk rather increase likelihood adverse effect contributes development antimicrobial resistance associated morbidity mortality",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40714362/",
        "source_type": "Global"
    },
    {
        "pmid": "40714040",
        "title": "Scientific and medical evidence informing expansion of hepatitis B treatment guidelines.",
        "abstract": "Chronic hepatitis B treatment relies nucleoside nucleotide analogue drug suppress hepatitis B virus HBV replication normalise liver enzymes slow disease progression excellent safety profiles Treatment curative patient remain risk cirrhosis hepatocellular carcinoma Treatment guideline generally restricted antiviral therapy individual high HBV DNA elevated ALT hepatic fibrosis often requiring longitudinal testing scarcely available resourcelimited settings Consequently fewer 3 people living HBV infection receiving antiviral therapy Guidelines China recently broadened access criterion antiviral therapy people fall outside guideline could still benefit treatment initiation pathological process induced HBV infection still active patients present benefit risk expanding treatment eligibility believe benefit reduced hepatic damage carcinogenic stimulus greatly outweigh risks",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40714040/",
        "source_type": "Global"
    },
    {
        "pmid": "40714036",
        "title": "Patient and public health perspectives to inform expansion of hepatitis B treatment guidelines.",
        "abstract": "Chronic hepatitis B associated considerable morbidity mortality worldwide People living hepatitis B face physical emotional social professional impacts reducing quality life Treatment nucleoside nucleotide analogue reduces risk liver cirrhosis liver cancer improves quality life However people globally offered access affordable longterm antiviral treatment Moreover little progress made towards meeting hepatitis B elimination targets global landscape shifting towards expanding treatment criteria discussion surrounding patient community perspective inadequate view treatment eligibility hepatitis B virus infection public health patientcentred approach Here discus potential benefit risk expansion implementation considerations public health questions data need surrounding expansion treatment eligibility conclude strong public health community rationale expanding treatment eligibility people living chronic hepatitis B",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40714036/",
        "source_type": "Global"
    },
    {
        "pmid": "40713827",
        "title": "Iparomlimab and tuvonralimab (QL1706) plus chemotherapy and bevacizumab for EGFR-mutant patients with advanced non-small cell lung cancer after failure of EGFR-tyrosine kinase inhibitors: updated results from cohort 5 in the DUBHE-L-201 study.",
        "abstract": "Iparomlimab tuvonralimab QL1706 bifunctional antiprogrammed death1cytotoxic Tlymphocyte antigen4 antibody combination bevacizumab doublet chemotherapy tolerable showed preliminary antitumor activity advanced nonsmall cell lung cancer NSCLC DUBHEL201 study Here report updated data longterm survival prognosis safety cohort 5 Epidermal growth factor receptor EGFRmutant patient progressed EGFRtyrosine kinase inhibitor TKIs enrolled cohort 5 received QL1706 5 mgkg combined bevacizumab pemetrexed carboplatin threeweek cycle four cycle followed maintenance therapy QL1706 bevacizumab pemetrexed Survival outcome adverse event followed up July 5 2024 median duration response progressionfree survival PFS overall survival OS 31 patient cohort 5 1133 month 95 confidence interval CI 4171991 851 month 95 CI 5721331 2651 month 95 CI 1281not reached respectively 23 742 patient received subsequent anticancer therapy disease progression median PFS 1002 months median PFS 851 month vs 595 months P  0622 median OS 3019 month vs 1068 months P  0177 appeared longer patient 21L858R mutation compared 19Del although difference statistically significant Grade ≥ 3 treatmentrelated adverse event occurred 13 419 patients Nineteen 613 patient immunerelated adverse events one 32 grade ≥ 3 new safety signal observed QL1706 combining pemetrexed carboplatin bevacizumab showed longterm favorable prognosis manageable safety profile advanced EGFRmutant patient NSCLC failure EGFRTKIs",
        "mesh_terms": [
            "Adult",
            "Aged",
            "Female",
            "Humans",
            "Male",
            "Middle Aged",
            "Antibodies, Bispecific",
            "Antibodies, Monoclonal, Humanized",
            "Antineoplastic Combined Chemotherapy Protocols",
            "Bevacizumab",
            "Carcinoma, Non-Small-Cell Lung",
            "Cohort Studies",
            "ErbB Receptors",
            "Lung Neoplasms",
            "Mutation",
            "Pemetrexed",
            "Protein Kinase Inhibitors",
            "Tyrosine Kinase Inhibitors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40713827/",
        "source_type": "Global"
    },
    {
        "pmid": "40711677",
        "title": "Utility of echocardiographic parameters in predicting cardiac immune-related adverse events in Japanese patients undergoing immune checkpoint inhibitor therapy.",
        "abstract": "Immune checkpoint inhibitor ICIs transformed cancer treatment associated immunerelated adverse events including cardiac immunerelated adverse event cardiac irAEs Early identification patient risk cardiac irAEs crucial echocardiographic parameter may serve valuable predictors study aimed evaluate predictive utility echocardiographic index assessing cardiac irAE risk Japanese patient receiving ICI therapy retrospective study analyzed patient treated ICIs University Fukui Hospital November 2015 October 2018 Cardiac irAEs defined according ESC guidelines Among 73 patients six 8 developed cardiac irAEs fatalities Echocardiographic assessment ICI initiation revealed patient later developed cardiac irAEs significantly lower ejection fraction EFs p  005 Receiver operating characteristic analysis demonstrated left ventricular endsystolic diameter LVDs area curve AUC  0660 EFs AUC  0797 moderate predictive value cardiac irAEs KaplanMeier analysis showed higher probability cardiac irAEs patient LVDs EFs beyond specific threshold p  001 Poisson regression analysis indicated decreasing risk cardiac irAEs time ICI initiation Baseline echocardiographic parameters particularly LVDs EFs useful predictor cardiac irAEs patient receiving ICI therapy Early echocardiographic evaluation may facilitate risk stratification improve monitoring strategy cardiac irAEs UMIN000023840",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40711677/",
        "source_type": "Global"
    },
    {
        "pmid": "40711508",
        "title": "Cocoon Vaccination Among Mothers of Very Preterm Infants.",
        "abstract": "Preterm survivor risk acquiring communicable disease postdischarge Cocoon strategy immunization close contact prevent infection vulnerable individuals study assessed coverage cocoon vaccine among mother preterm infants retrospective study analyzed proportion mother preterm  30 weeks infant received eligible cocoon vaccine tetanus diphtheria acellular pertussis Tdap influenza varicella antenatal postnatal period Seventyfive 159 472 mother received three cocoon vaccines median postnatal age receiving vaccine 38 23 55 days Influenza Tdap vaccine administered 641 485 mothers respectively either antenatally postnatally 492 34 69 father covered cocoon vaccines Less 50 mother compliant cocoon vaccination protocol call intensive effort towards improving vaccine coverage among close contact highrisk infants",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40711508/",
        "source_type": "Global"
    },
    {
        "pmid": "40705454",
        "title": "Dietary salt intake worsens the Th17-dependent inflammatory profile of patients with cirrhosis.",
        "abstract": "Background  AimsLiver cirrhosis characterized chronic inflammation fibrosis Th17 cell playing crucial role progression Recent evidence suggests dietary salt influence immune disease modulating Th17 differentiation study assessed impact dietary salt Th17driven inflammation patient compensated cirrhosis explored effect liver injury mouse modelsMethodsA nondrug openlabel nonrandomized study involved 37 patient compensated cirrhosis given personalized guideline reduce salt intake three months Changes Th17driven inflammation liver function marker assessed baseline salt restriction parallel impact highsalt diet hepatic CD4 cell analyzed mouse model acute liver injury fibrosis ResultsHigh salt intake associated Th17mediated inflammation correlated marker impaired liver function patients Importantly moderating salt intake personalized nutritional intervention sufficient reduce CD4 cell mediated inflammation Furthermore analysis RNAseq data revealed enrichment saltinduced Th17 gene signature liver tissue peripheral cell patient liver disease Similarly mouse fed high salt diet showed hepatic enrichment Th17 cell exacerbated liver fibrosis upon injury Mechanistic study revealed high sodium condition activated NFκB induced IL6 production hepatocytes may promote Th17 responsesConclusionDietary salt exacerbates Th17driven inflammation contributes cirrhosis progression Salt reduction may represent viable therapeutic approach manage inflammation compensated cirrhosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40705454/",
        "source_type": "Global"
    },
    {
        "pmid": "40705199",
        "title": "Proteomic profiling reveals dynamic regulation of vesicle trafficking across glioma grades.",
        "abstract": "Gliomas highly heterogeneous central nervous system tumor evolve progressive molecular reprogramming cell proliferation adhesion mechanism wellcharacterized contribution vesicle trafficking glioma progression remains underexplored study aimed characterize proteomic change across glioma grades performed untargeted quantitative proteomic profiling glioma tissue across grade IIV using combination Tandem Mass Tag TMT11plex labeling highresolution liquid chromatographymass spectrometry LCMS Tissue sample processed using filteraided sample preparation FASP analyzed using µPAC reversephase HPLC system coupled highresolution mass spectrometer Protein identification quantification conducted database searching validated stringent quality control criteria identified 4400 protein across samples revealing dynamic gradespecific shift vesicle trafficking Grade II glioma showed upregulation exocytic protein eg synaptotagmin syntaxin clathrin suppression dynamin suggesting enhanced vesicular secretion Grade III tumor exhibited opposite trendmarked downregulation exocytic component concurrent activation clathrinmediated endocytosis Grade IV glioma displayed hybrid profile partial reactivation exocytic machinery alongside sustained endocytic activity indicative vesicular plasticity study highlight synaptic vesicle cycle progressively remodeled pathway glioma biology finding suggest vesicle trafficking critical underrecognized feature glioma pathogenesis may represent novel axis therapeutic exploration",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40705199/",
        "source_type": "Global"
    },
    {
        "pmid": "40699418",
        "title": "Guidelines for RNA Analysis by Reverse Transcription Quantitative Polymerase Chain Reaction.",
        "abstract": "Reverse transcription quantitative polymerase chain reaction RTqPCR stand essential molecular biology tool analyzing gene expression offering precise accurate measure gene expression levels significance critical unraveling cellular process deciphering complexity disease mechanisms chapter detail comprehensive methodology obtaining highquality RNA cell culture followed RNA extraction columnbased purification steps reverse transcription RT convert RNA complementary DNA cDNA quantitative PCR qPCR performed Protocols utilizing oligodT random hexamers cDNA synthesis described Furthermore employed two different assay qPCR TaqMan SYBR Green ensure thorough examination gene expression technique valuable resource researcher want study gene expression wide range biological contexts",
        "mesh_terms": [
            "RNA",
            "Reverse Transcriptase Polymerase Chain Reaction",
            "Humans",
            "Real-Time Polymerase Chain Reaction",
            "DNA, Complementary",
            "Gene Expression Profiling"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40699418/",
        "source_type": "Global"
    },
    {
        "pmid": "40687163",
        "title": "Evaluation of acute flaccid paralysis surveillance system in Kebbi State, Nigeria between 2013-2018.",
        "abstract": "since 1988 polio incidence declined 99 globally 350000 annual case 125 endemic country transmission limited Pakistan Afghanistan Africa reported wild poliovirus since 2016 effective Acute Flaccid Paralysis AFP surveillance system crucial detecting interrupting polio transmission evaluation assessed Acute Flaccid Paralysis AFP surveillance system Kebbi State Nigeria identify operational gaps using updated Center Disease Control Prevention CDC guideline World Health Organization WHO performance standards study reviewed AFP surveillance data 20132018 conducted stakeholder interview using adapted questionnaire key informant interviews analyzed data using means frequencies proportions among 49 respondents 98 reported case definition investigation form easy use 97 found data tool adaptable changes surveillance officer understood AFP case definition expressed willingness sustain system Key performance indicators including nonpolio AFP rate 246552 stool adequacy 95997 timeliness reporting completeness consistently met standards evaluation concluded AFP surveillance system Kebbi State Nigeria useful simple flexible acceptable sensitive representative timely stable although donor dependency remains concern significant gap lack data 60day followup laboratory feedback Addressing issue important strengthen system",
        "mesh_terms": [
            "Nigeria",
            "Humans",
            "Poliomyelitis",
            "Population Surveillance",
            "Paralysis",
            "Incidence",
            "Surveys and Questionnaires",
            "Acute Disease",
            "World Health Organization"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40687163/",
        "source_type": "Global"
    },
    {
        "pmid": "40685343",
        "title": "Impact of the new Japanese medical specialty system on residents' career choices in general medicine: a nationwide cross-sectional study.",
        "abstract": "General medicine GM formally recognized specialty Japan 2018 address need primary care Understanding factor influencing GM career choice critical recruitment However reforms impact career decisionmaking remains unclear study examined factor influencing GM career choice following introduction new specialty certification identified challenge field secondary analysis national survey data Ministry Health Labour Welfares questionnaire 20182020 clinical training graduate examined posttraining career intention specializing GM focusing factor influencing choice demographics education training contexts Multivariable logistic regression conducted posttraining GM preference dependent variable result expressed adjusted odds ratio aORs 95 confidence interval CIs Among 16674 complete responses 59 229 individual initially interested GM actually pursued posttraining Positive factor included regional quota aOR 310 95 CI 112856 ≤ 1 month GM rotation aOR 339 95 CI 1031114  2 month community medicine CM rotation aOR 1335 95 CI 2407658 desire primary care skill aOR 485 95 CI 2011173 community contribution aspiration aOR 688 95 CI 2751721 influential negative factor perceived ease specialization maintenance aOR 001 95 CI 000012 Among 16445 individual preferred specialties 86 switched GM Extended GM rotation 1≤2 months aOR 354 95 CI 206609 2 months aOR 741 95 CI 4561204 increased likelihood switching Academic interest aOR 036 95 CI 023058 perceived ease maintaining specialization aOR 013 95 CI 003054 negative factors GM rotation may positively influence career choices longer CM rotation potentially increasing interest Establishing clear career path educating resident physician academic characteristic GM remain challenging despite recognition specialty",
        "mesh_terms": [
            "Career Choice",
            "Humans",
            "Cross-Sectional Studies",
            "Japan",
            "Female",
            "Male",
            "Adult",
            "Internship and Residency",
            "General Practice",
            "Surveys and Questionnaires",
            "Specialization",
            "East Asian People"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40685343/",
        "source_type": "Global"
    },
    {
        "pmid": "40685137",
        "title": "Splenectomy for immune thrombotic thrombocytopenic purpura: a systematic review and meta-analysis.",
        "abstract": "Immune thrombotic thrombocytopenic purpura iTTP thrombotic microangiopathy caused autoantibodymediated ADAMTS13 deficiency Historically splenectomy used multiply relapsing iTTP clinical remission lessen risk relapse treatment plasmarefractory plasmadependent iTTP evaluate effectiveness splenectomy relapse relapsing iTTP remission plasmarefractory palsmadependent iTTP conducted systematic review metaanalysis 2 question related splenectomy iTTP 1 patient relapsing iTTP effect splenectomy iTTP relapse rate 2 patient plasmarefractory plasmadependent iTTP proportion patient achieve clinical remission splenectomy Three electronic database Embase PubMed Scopus searched keywords related thrombotic thrombocytopenic purpura splenectomy screening completed following PRISMA guidelines Twentythree study included representing 62 patient with 2058 year followup underwent splenectomy relapsing iTTP 57 patient with 1739 year followup reported 3 studies underwent splenectomy plasmarefractorydependent iTTP patient underwent splenectomy relapsing iTTP 180 95 CI 266 095 fewer iTTP episode annually splenectomy compared splenectomy patient underwent splenectomy plasmarefractorydependent iTTP proportion patient achieving clinical remission 087 95 CI 076093 2 study included patient received rituximab lowquality evidence support use splenectomy multiply relapsing iTTP decrease relapse rate plasmarefractorydependent iTTP achieve remission noting evidence precedes routine use rituximab iTTP",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40685137/",
        "source_type": "Global"
    },
    {
        "pmid": "40684150",
        "title": "COVID-19 infection and its association with severe malaria & dengue: an epidemiological study from Southern India.",
        "abstract": "PostCoronavirus Disease19 COVID19 sequela involve complex biological process alter progression clinical outcome infectious diseases However documented information influence COVID19 development severe malaria dengue Hence study conducted determine association malaria  dengue previous COVID19 infection among adult population Mangalore Taluk describe sociodemographic clinical correlate malaria  dengue casecontrol study conducted among 293 participant positive either malaria dengue November 2022 August 2024 Data collected using proforma contained section demographic details clinical profile comorbidities history COVID19 infection COVID19 vaccination status participant categorised severe disease mild moderate disease based operational definitions data analysed using Statistical Package Social Sciences SPSS version 29 Chisquare test done pvalue less 005 considered statistically significant Binary Logistic Regression analysis used odds ratio estimated total 293 participant included study mean age 367 SD148 years Among them 239 n  70 malaria 761 n  223 dengue malaria 30 n  21 developed severe illness whereas among dengue 358 n  80 developed severe dengue Overall 584 n  171 age group  30 years total 981 n  52 participant dengue fever history COVID19 infection developed severe dengue aOR5593 95 CI71743592 p  0001 compared without Similarly 857 n  12 participant history COVID19 infection developed severe malaria aOR 2637 95 CI 34919874 p  0001 compared difference found statistically significant addition participant belonging lower socioeconomic class higher chance developing severe dengue belonging upper socioeconomic class p  0001 prior history COVID19 infection higher chance developing severe malaria dengue without history COVID19 infection",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "India",
            "Male",
            "Female",
            "Adult",
            "Case-Control Studies",
            "Middle Aged",
            "Dengue",
            "Malaria",
            "SARS-CoV-2",
            "Young Adult",
            "Severity of Illness Index"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40684150/",
        "source_type": "Global"
    },
    {
        "pmid": "40684080",
        "title": "Characteristics of eclampsia not preceded by hypertensive disorders of pregnancy: a case control study.",
        "abstract": "Eclampsia traditionally considered complication hypertensive disorder pregnancy HDP However atypical case occur without preceding HDP pathophysiological mechanism remain unclear study aimed compare clinical feature eclampsia without prior HDP diagnosis retrospectively analyzed 31 singleton pregnancy eclampsia diagnosed nine Japanese perinatal center 2007 2023 Cases classified two groups eclampsia preceded HDP n  14 eclampsia preceded HDP n  17 Clinical characteristics laboratory findings perinatal outcome compared 31 case eclampsia 17 57 preceded HDP remaining case diagnosed HDP prior onset eclampsia eclampsia preceded HDP group compared eclampsia preceded HDP group BMI significantly lower 2207 ± 205 vs 2560 ± 619 kgmsup2sup P  0047 gestational week delivery significantly later median 400 320410 vs 375 260410 weeks P  0020 proportion male neonate significantly higher 588 vs 143 P  0024 comparing onset periodsantepartum intrapartum postpartumthe eclampsia preceded HDP group exhibited highest number case intrapartum period 9 cases eclampsia preceded HDP group showed highest number postpartum period 8 cases Furthermore eclampsia preceded HDP group white blood cell count significantly higher immediately onset 20626 ± 7956 vs 14687 ± 5664 μL P  0039 Atypical eclampsia without preceding HDP show distinct clinical features including later gestational age onset higher intrapartum incidence elevated inflammatory markers finding suggest need investigation alternative pathophysiological mechanism tailored clinical strategy cases",
        "mesh_terms": [
            "Humans",
            "Female",
            "Pregnancy",
            "Eclampsia",
            "Retrospective Studies",
            "Adult",
            "Hypertension, Pregnancy-Induced",
            "Case-Control Studies",
            "Infant, Newborn",
            "Male",
            "Gestational Age",
            "Japan",
            "Pregnancy Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40684080/",
        "source_type": "Global"
    },
    {
        "pmid": "40684072",
        "title": "Strategies for the Prevention and Management of Respiratory Infections in Patients at High Risk in the UAE: A Cross-Disciplinary Position Paper.",
        "abstract": "Respiratory infection major cause mortality among young child adults particularly elderly underlying medical conditions Many respiratory infections including influenza COVID19 pneumococcal disease respiratory syncytial virus RSV available vaccine antiviral agents However vaccine coverage rate remain low Experts representing broad spectrum medical specialty United Arab Emirates UAE made evidencebased recommendation treating patient considered high risk respiratory infections highlighting gap current practice suggesting strategy improved communication healthcare professional patients effectively manage respiratory infections expert emphasized importance adhering guidelines considering vaccine antiviral treatments strictly following vaccination schedules Early testing upon recognition symptom also encouraged Improving vaccine uptake considered crucial could achieved educating patient disease prevention vaccine role antiviral treatment COVID19 Addressing knowledge gap combating vaccine hesitancy among patient healthcare professional also essential steps Recommendations future initiative include healthcare professional educating public precautionary measure reduce spread respiratory infections Additionally expert agreed clinical management guideline chronic disease updated include preventative strategy vaccines prophylaxis counselling Monitoring performance healthcare facility using key performance indicator also recommended ensure effective management continuous improvement vaccination programs Patient population UAE considered high risk serious disease respiratory infection diverse medical need may access healthcare across wide range setting specialisms Therefore vital healthcare professional across specialism may engage individual able provide appropriate advice managing risk vaccination prompt testing treatment needed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40684072/",
        "source_type": "Global"
    },
    {
        "pmid": "40681843",
        "title": "Peripartum sertraline impacts maternal neurobehavioral and neurodegenerative mechanisms in pregnant and postpartum mice.",
        "abstract": "Selective Serotonin Reuptake Inhibitors SSRIs among common medication used depression postpartum lactating people experience increased depression risk However limited understanding peripartum SSRI impact maternal neurobehavioral responses particularly sertraline prescribed SSRI United States US pregnancies administered C57Bl6 female sertraline via noninvasive naturalistic approach 167 mgL drinking water 2 week preconception lactation PND21 equivalent duration nonpregnant controls assessed behavior molecular brain change intrapartum postpartum 1 year age Chronic sertraline reduced depressive anxietylike behaviors Pregnancy decreased anxietylike hedonic behaviors RNA sequencing maternal brain revealed 52 differentially expressed gene DEGs frontal cortex sertraline DEGs overrepresented function related immunity contrast sertraline altered 962 target maternal hypothalamic paraventricular nucleus DEGs overrepresenting neurotransmission neurodegeneration discontinued sertraline aged animal approximately 1 year test neurodegenerative phenotypes one prior litter regardless peripartum sertraline improved aged females spatial learning memory Sertraline regardless postpartum status improved working memory Further found buffering neurodegenerationrelated gene network change increased excitatory synapse density hippocampus peripartum sertraline Peripartum sertraline alters maternal neurobiology behavior pregnancy beyond longterm benefit neurodegenerative processes Pregnancy also exerts own lasting effect learning memory finding might exploited future abrogate neurodegenerative disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40681843/",
        "source_type": "Global"
    },
    {
        "pmid": "40678818",
        "title": "Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey.",
        "abstract": "Treating rheumatic musculoskeletal disease RMDs pregnancy breastfeeding present significant complexities mainly due inconsistency clinical guidance document reference safety information including summary product characteristic SmPC patient information leaflet PIL assess healthcare professionals HCPs prescribing behaviors comfort levels challenge advising patients focusing discrepancy clinical guidance document SmPCPIL Online survey entitled PRAISE Perception healthcare provider Regarding Antirheumatics pregnancy breastfeeding advice Information patient perSpEctives disseminated HCPs group social media crosssectional survey conducted among 414 HCPs globally Respondents divided prescribers ini  336 nonprescribers ini  78 based selfreported role prescribing antirheumatic medication pregnant breastfeeding patient RMDs survey covered demographics clinical experience confidence prescribing use clinical guidelines experience managing conflicting information guideline SmPCPIL Prescribers likely nonprescribers feel comfortable discussing medication safety pregnancy prescribers found clinical guidance document useful 48 rating very useful 38 extremely useful case conflicting information clinical guidance document SmPCPIL 58 HCPs reported caused confusion tension patientdoctor relationships almost 20 likely very likely discontinue ongoing treatment Clear communication shared decisionmaking common strategy used address patient concerns HCPs often face significant challenge advising patient RMDs use medication pregnancy breastfeeding Conflicting information clinical guidance document SmPCPIL disrupt patientdoctor relationship lead treatment discontinuation potential consequence maternal disease control Improved alignment clinical guidance document SmPCPIL could enhance patient care prevent confusion among HCPs patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40678818/",
        "source_type": "Global"
    },
    {
        "pmid": "40668326",
        "title": "COVID-19 Disruption and Maternal and Child Health Services: Evidence from India.",
        "abstract": "analyze impact COVID19 subsequent lockdown maternal child health service India investigate whether certain population group disadvantaged along social economic geographical dimension experienced differential impacts Utilizing unintended disruption fifth round National Family Health Survey NFHS V due nationwide COVID19 related lockdown create sample child mother exposed COVID19 pandemic lockdowns exposed use multivariable regression examine whether extent antenatal care pregnancy postpregnancy care exposed mother child adversely impacted compared unexposed exposed mother less likely receive two tetanus injections iron folic acid tablet pregnancy less likely stay medical facility 48 hour postdelivery recommended government guidelines critically exposed child lower probability receiving immunization due birth 6weeks 10weeks 14weeks magnitude decline increasing successive immunizations impact even adverse rural area reflected heterogeneity analysis COVID19 pandemic lockdown adversely affected MCH service India even rural India Policy intervention targeted specifically group impacted would needed restore MCH service prepandemic levels Applicable",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40668326/",
        "source_type": "Global"
    },
    {
        "pmid": "40665314",
        "title": "Immune checkpoint inhibitors and the pediatric rheumatologist: a pediatric needs assessment.",
        "abstract": "use immune checkpoint inhibitor ICI therapy increasing pediatric oncology ICIs cause rheumaticimmune related adverse event RhirAEs inflammatory arthritis myositis case report detail RhirAEs management pediatric population objective assess familiarity pediatric rheumatologist PRs worldwide RhirAEs gauge confidence managing conditions identify knowledge gap guide future educational efforts circulated online survey 2084 PRs via Dr Peter Dent Pediatric Rheumatology Bulletin Board Responses collected June 2024 September 2024 collected data practitioner demographics knowledge ICIs RhirAEs confidence managing RhirAEs preferred educational resources Sixtynine participant responded 55 80 PRs academic centers Despite global distribution 56 81 response came North America Thirtyfour 49 respondent aware ICIs related mechanisms indications side effects 40 58 familiar irAEs Fiftyfive 80 never managed patient RhirAEs Among 1469 21 median number case managed 20 IQR 00 Thirtynine respondent not confident all managing RhirAEs 34 not confident all managing preexisting autoimmune disease PAD ICI users 46 not confident all advising oncology colleague initiating discontinuing ICIs context RhirAEs preexisting autoimmune disease PAD respondent felt completely confident managing conditions Participants identified knowledge gap longterm management acute management recognition diagnosis Fortythree indicated need pediatricspecific clinical guidelines 14 respondent clinical experience treating RhirAEs treatment varied 4 using nonsteroidal antiinflammatory drugs 3 using prednisone 4 combining prednisone methotrexate Longterm management also varied 5 using methotrexate 3 using tumor necrosis factor inhibitors Significant knowledge gap lack confidence exist among PRs managing ICIrelated RhirAEs ICI use increase pediatric oncology PRs exposure RhirAEs follow Targeted educational program clinical guideline may valuable address gaps",
        "mesh_terms": [
            "Humans",
            "Immune Checkpoint Inhibitors",
            "Rheumatologists",
            "Child",
            "Needs Assessment",
            "Rheumatic Diseases",
            "Surveys and Questionnaires",
            "Male",
            "Female",
            "Rheumatology",
            "Pediatrics",
            "Clinical Competence",
            "Neoplasms"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40665314/",
        "source_type": "Global"
    },
    {
        "pmid": "40662744",
        "title": "Lessons learned from successful implementation of tetanus and diphtheria vaccination programs.",
        "abstract": "SUMMARYVaccines tetanus diphtheria known legacy vaccine developed 1920s long establishment modern immunology time Food  Drug Administration FDA still infancy Despite lacking technological advance today medical intervention represent two successful vaccine ever developed indicated incidence disease falling less one case tetanus per 10 million personyears approximately one case diphtheria per 1 billion personyears US population Here compare success tetanus diphtheria vaccination program common childhood vaccine review evidencebased approach adult booster vaccination schedules finding indicate completing childhood vaccination series decennial booster vaccination may longer needed maintain protective immunity general population Moreover updating current vaccination program remove adult decennial booster dos harmonize US recommendation guideline World Health Organization WHO may also improve riskbenefit ratio vaccination providing 1 billion annually healthcare savings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40662744/",
        "source_type": "Global"
    },
    {
        "pmid": "40662276",
        "title": "Prevalence of hypertension in Africa in the last two decades: Systematic review and meta-analysis.",
        "abstract": "Despite common cardiovascular risk factor actual burden hypertension poorly characterized Africa metaanalyzed extensive pooled data determine overall prevalence hypertension Africa Following PRISMA guidelines systematically searched Google Scholar PubMed ScienceDirect Web Science database retrieve prevalence study hypertension among Africans published 2002 2023 Furthermore metaanalyzed crude ageadjusted prevalence hypertension using random effect model due expected high heterogeneity logit transformation original proportionsSeventyeight out initial 779 screened article complete data included total number hypertension case 71004 denominator population 286575 mostly communitybased study 23 countries pooled crude prevalence hypertension 28⸱5100 person 95 confidence interval CI 25⸱331⸱8 95 prediction interval 7⸱665⸱6 pooled prevalence increased age highest among aged ≥75 years 51⸱4 95CI 42⸱060⸱6 remained highest Southern Africa region overall 34⸱8 last decade 20132023 44⸱5 point estimate pooled crude prevalence higher among urban dwellers 32⸱9 95CI 26⸱839⸱5 rural residents 26⸱3 95CI 20⸱433⸱3 subset twentyone article reporting age stratification consistent standard population pooled agestandardized prevalence 27⸱2100 person 95CI 20⸱933⸱6 burden hypertension remains high especially urban area increasing age Frequent screening treatment recommended especially urban areas",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40662276/",
        "source_type": "Global"
    },
    {
        "pmid": "40660196",
        "title": "Variation in measles seroprevalence among medical students based on place and year of birth: Ege University experience.",
        "abstract": "Measles despite vaccinepreventable disease remains significant global health concern crucial healthcare workers serve first line contact infected individuals properly immunized study aimed investigate change measles seroprevalence among Ege University Faculty Medicine student 2010 2024 Medical faculty student underwent antimeasles Immunoglobulin G screening Infectious Diseases Clinic Ege University Faculty Medicine Hospital İzmir Turkey January 1 2010 January 31 2024 included study demographic data participant recorded electronic patient files study included 1448 medical students 519 n  751 male mean age 2128 ± 148 years Measles seropositivity observed 461 participant n  668 Among born 1998 2004 seropositivity 238 whereas significantly higher 675 born 1986 1997 p  0001 Pearson correlation analysisof measles seroprevalence birth year revealed strong negative statistically significant relationship r0964 p  0001 analyzed place birth lowest measles seroprevalence observed Eastern Marmara region 345 study emphasizes substantial number young healthcare worker still vulnerable measles posing potential risk outbreaks Early screening vaccination medical student vaccinepreventable disease essential education proactive strategy protects individual also strengthens herd immunity",
        "mesh_terms": [
            "Humans",
            "Measles",
            "Seroepidemiologic Studies",
            "Male",
            "Turkey",
            "Female",
            "Students, Medical",
            "Young Adult",
            "Adult",
            "Universities"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40660196/",
        "source_type": "Global"
    },
    {
        "pmid": "40655295",
        "title": "Regional Disparities and Maternal Sociodemographic Determinants of Full Immunization Coverage Among Children Aged 12-23 Months in Nigeria: Insights from NDHS 2018.",
        "abstract": "Childhood immunization crucial reducing morbidity mortality vaccinepreventable diseases Despite global efforts Nigeria face persistently low immunization uptake significant regional socioeconomic disparities study investigated prevalence regional disparities sociodemographic determinant full immunization coverage among child aged 1223 month Nigeria secondary analysis utilized data 2018 Nigeria Demographic Health Survey NDHS focusing 2453 mother child aged 1223 months Full immunization coverage defined per World Health Organization WHO guidelines Descriptive statistics bivariate analysis multivariable logistic regression identified predictor coverage 26 child fully immunized nationwide Marked regional disparity observed North West 13 North East 18 exhibiting lowest rates South East 42 South South 41 highest Multivariable analysis revealed maternal education household wealth region residence significant predictors Children mother higher education likely fully immunized AOR 187 95 CI 110318 p  0022 richest household compared poorest AOR 320 95 CI 195525 p  0001 Children South East AOR 200 95 CI 116346 p  0013 South South AOR 173 95 CI 099302 p  0052 also showed significantly higher odds full immunization compared North West Full immunization coverage Nigeria remains critically low driven pronounced regional socioeconomic inequities Targeted intervention focusing improving maternal education expanding equitable healthcare access underserved regions providing financial support lowincome family essential Policy effort must prioritize vulnerable group enhance child health outcome achieve universal immunization coverage Nigeria",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40655295/",
        "source_type": "Global"
    },
    {
        "pmid": "40652272",
        "title": "Differential prognostic roles and clinical implications of mitochondrial and genomic tRNA-derived fragments in colorectal liver metastases.",
        "abstract": "Colorectal liver metastasis CRLM leading cause colorectal cancer CRCrelated mortality Transfer RNAderived fragment tRFs novel class small noncoding RNAs sncRNA regulate gene expression stress response immune function cancer increasingly implicated CRC progression prognostic significance CRLM remains unknown study investigates abundance prognostic value genomic ge mitochondrial mt tRFs CRLM Tumor sample CRLM patient underwent curative liver resection January 2012 December 2015 retrospectively analyzed Small RNA sequencing sRNAseq quantified ge mttRF expression tumor tissue Eventfree survival EFS primary outcome Associations tRF expression EFS evaluated using Cox regression spline modeling network analysis Among 588 screened samples 40 met eligibility criterion 18 female 45 median age 64 4279 total 432 tRFs identified getRFs 67 abundant mttRFs 33 Spline regression classified tRFs ten prognostic groups High getRF abundance predominantly associated unfavorable EFS FDR  02 94 mttRFs significantly p  0001 χsup2sup test often linked favorable EFS FDR  02 26 Network analysis tRF abundance correlation revealed higher intramitochondrial network density compared intragenomic tRF network significant structural difference observed prognostically significant vs nonsignificant favorable vs unfavorable tRFs Key tRF candidates including tRHalve3HisCAU tRNAleaderGlnUUG mttRFs well tRFmiscTyrGTA getRF remained independent prognostic marker adjusting clinical covariates study provides first comprehensive characterization tRF expression CRLM identifying distinct prognostic role ge mttRFs getRFs correlated poor prognosis several mttRFs linked favorable outcomes highlighting potential novel prognostic biomarkers therapeutic targets",
        "mesh_terms": [
            "Humans",
            "Colorectal Neoplasms",
            "Female",
            "Prognosis",
            "Male",
            "Liver Neoplasms",
            "Middle Aged",
            "RNA, Transfer",
            "Aged",
            "Mitochondria",
            "Adult",
            "Disease-Free Survival",
            "Genomics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40652272/",
        "source_type": "Global"
    },
    {
        "pmid": "40652233",
        "title": "Assessment of nursing staff attitude regarding prevention of cervical cancer.",
        "abstract": "Cervical cancer third commonly diagnosed cancer among woman worldwide Egypt considered 14th major contributor female tumors assess nursing staff attitude regarding prevention cervical cancer descriptive crosssectional study framework executed Mansoura University Hospital six building psychiatry burns outpatient special medicine convalescence radiation building Mansoura city Egypt among 414 nursing staff chosen using convenience sampling technique structured interview questionnaire consisting two part used gather data June 2024 continued end November 2024 Univariate analysis descriptive data bivariate analysis chisquare test performed current research revealed 763 studied nursing staff positive attitude toward prevention cervical cancer 693 agreed cervical neoplasm highly preventable disease 717 agreed cervical neoplasm curable detected early Also statistically significant positive association educational level attitude p  0001 statistically significant positive association marital status attitude p  0031 Also statistically significant positive association vaccination HPV positive attitude p  0001 statistically significant positive association positive attitude cervical cancer screening p  0012 concluded threequarters nursing staff demonstrated positive attitude toward cervical cancer prevention underscoring need continued educational interventions study registered clinical trial involve interventional design",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40652233/",
        "source_type": "Global"
    },
    {
        "pmid": "40647371",
        "title": "Screening for Cervical Cancer: A Comprehensive Review of Guidelines.",
        "abstract": "Cervical cancer remains one main cause female mortality especially middle lowincome countries despite effort towards implementation global vaccination human papillomavirus HPV aim study review compare recently published international guideline providing recommendation cervical cancer screening strategy among average highrisk women Thus comparative review guideline US Preventive Services Task Force USPSTF American Cancer Society ACS American Society Clinical Oncology ASCO World Health Organization WHO Canadian Task Force Preventive Health Care CTFPHC Cancer Council Australia CCA European Guidelines EG conducted overall agreement regarding suggestion made woman younger 21 older 65 guideline stating routine screening exception CTFPHC CCA expand age group 70 75 years respectively Continuation screening older woman also suggested history precancerous lesion inadequate screening guideline recommend routine screening 3065 years advises screening prioritized 3049 years HPV DNA testing method choice recommended guidelines followed cytology alternative except CTFPHC refers cytology only selfsampling acceptable method medical societies Agreements exist regarding recommendation specific groups woman history total hysterectomy benign reasons woman complete vaccination HPV individual lesbian gay bisexual transgender queer community woman multiple sexual partner early initiation sexual activity hand age group 2129 addressed differently reviewed guidelines differentiation also occur screening strategy case abnormal screening results woman immunodeficiency utero exposure diethylstilbestrole pregnant women development consistent practice protocol appropriate cervical cancer screening program seems major importance reduce mortality rate safely guide everyday clinical practice",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40647371/",
        "source_type": "Global"
    },
    {
        "pmid": "40647258",
        "title": "Functional Foods in Modern Nutrition Science: Mechanisms, Evidence, and Public Health Implications.",
        "abstract": "recent years functional food garnered increasing scientific public health interest due potential confer physiological benefit beyond basic nutritional value International body EFSA FDA define functional food containing bioactive component may contribute prevention management chronic noncommunicable diseases including cardiovascular disease type 2 diabetes certain cancers evolving paradigm food medicine reflects broader shift nutritional science towards proactive healthoriented dietary strategies article provides comprehensive interdisciplinary overview functional food examining biological mechanisms clinical evidence public health significance regulatory frameworks future prospectsparticularly context advance personalized nutrition nutrigenomics thorough literature review conducted drawing recent peerreviewed study guideline key health authorities review highlight role specific compound probiotic prebiotics modulating gut microbiome flavonoid polyphenols antiinflammatory processes omega3 fatty acid cardiometabolic regulation vitamin mineral supporting immune function expanding body clinical trial metaanalyses support health benefit compoundsincluding reduction LDL cholesterol improved insulin sensitivity mitigation oxidative stressthe integration functional food everyday diet remains challenging Socioeconomic disparity limited health literacy often impede accessibility widespread adoption public health practice Functional food represent promising component preventionfocused modern healthcare maximize impact coordinated evidencebased approach essential involving collaboration among healthcare professionals nutrition scientists policymakers food industry Looking forward innovation artificial intelligence microbiome research genomic technology may unlock novel opportunity targeted effective application functional food population health",
        "mesh_terms": [
            "Humans",
            "Functional Food",
            "Public Health",
            "Nutritional Sciences",
            "Gastrointestinal Microbiome",
            "Nutrigenomics",
            "Nutritive Value",
            "Cardiovascular Diseases",
            "Prebiotics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40647258/",
        "source_type": "Global"
    },
    {
        "pmid": "40645616",
        "title": "Basel Long COVID Cohort Study (BALCoS): protocol of a prospective cohort study.",
        "abstract": "recent pandemic caused SARSCoV2 profound global impact many individual recovered COVID19 developed longlasting symptom significantly disrupted daily life defines condition postCOVID19 condition PCC Common symptom include fatigue dyspnoea sleep disturbance cognitive difficulties Increasing evidence suggests PCC multifactorial condition shaped biomedical also psychological social factors article present protocol Basel Long COVID Cohort Study BALCoS aim improve understanding PCC capturing clinical functional psychosocial aspect repeated assessment course 1 year BALCoS prospective singlesite cohort study Inclusion criterion include either probable confirmed history SARSCoV2 infection persistent symptom consistent definition PCC sufficient German language skill age ≥18 years baseline collected detailed information previous SARSCoV2 infections symptom history reinfections COVID19 vaccination status preexisting medical conditions study includes standardised psychometric assessments physical performance tests ecological momentary assessment EMAs neurocognitive testing blood sample collection Assessments scheduled baseline 3month 6month 12month followup participant complete psychometric assessment time point Blood sample collected baseline Neurocognitive testing physical performance measure collected baseline 12month followup inperson participant only Participants unable attend person complete remote version study excluding inclinic assessments EMAs initiated day time point consist eight question 10 consecutive days study exploratory nature target sample size 120 participants BALCoS part Horizon Europe Long COVID project multinational interdisciplinary research consortium integrating mechanistic clinical interventional studies study approved Ethics Commission Northwest Central Switzerland BASECID 202300359 registered ClinicalTrialsgov ID NCT05781893 participant provide written informed consent Study finding disseminated peerreviewed publications NCT05781893",
        "mesh_terms": [
            "Female",
            "Humans",
            "Male",
            "COVID-19",
            "Post-Acute COVID-19 Syndrome",
            "Prospective Studies",
            "Psychometrics",
            "Research Design",
            "Switzerland",
            "Observational Studies as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40645616/",
        "source_type": "Global"
    },
    {
        "pmid": "40643781",
        "title": "Association of HLA-DRA, HLA-DQA1, and IL-6 gene variations with susceptibility to multiple sclerosis.",
        "abstract": "Multiple sclerosis MS lead severe physical cognitive disability neurological deficits chronic autoimmune disease affecting central nervous system CNS etiology pathogenesis MS remain unclear nonetheless asserted cause complex genetic predisposition playing significant role study aim analyze relationship MS HLADRA rs3135388 rs3135391 HLADQA1 rs9272346 IL6 rs1800795 rs1900796 gene polymorphisms play important role inflammation immune response study included 100 healthy control 98 MS patients Realtime polymerase chain reaction RTPCR used analyze variation rs3135388 rs3135391 HLADRA gene rs9272346 HLADQA1 gene rs1800795 rs1900796 IL6 gene following DNA isolation peripheral blood Statistical technique applied assess outcomes result showed significant difference IL6 rs1800796 GC p  0024 patient control group genotype allele distribution analyzed HLADQA1 rs9272346 HLADRA rs3135388 rs3135391 variation substantially differ two groups Similarly significant difference found two group VitD B12 folic acid parameters relationship parameter genotypes evidence suggesting significant association IL6 rs1800796 polymorphism MS IL6 rs1800796 GC genotype may associated disease susceptibility risk taken account association intervention study MS",
        "mesh_terms": [
            "Humans",
            "HLA-DQ alpha-Chains",
            "Interleukin-6",
            "Genetic Predisposition to Disease",
            "Multiple Sclerosis",
            "Female",
            "Male",
            "Adult",
            "Polymorphism, Single Nucleotide",
            "Case-Control Studies",
            "HLA-DR alpha-Chains",
            "Middle Aged",
            "Gene Frequency",
            "Genotype",
            "Alleles",
            "Genetic Association Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40643781/",
        "source_type": "Global"
    },
    {
        "pmid": "40640171",
        "title": "PLIN2 promotes colorectal cancer progression through CD36-mediated epithelial-mesenchymal transition.",
        "abstract": "Colorectal cancer CRC one common malignant tumor high incidence mortality challenge remains construct reliable prognostic prediction model elucidate key molecular mechanism tumor progression address this performed WGCNA based 120 immune cell expression profile GEO source obtain collection monocytesmacrophagesrelated genes prognostic model constructed univariate survival analysis LASSO regression analysis Then prognostic model validated Multivariate Cox regression KaplanMeier survival analysis ROC analysis prognostic model identified PLIN2 potential value CRC prognosis PLIN2 expression monocytesmacrophages verified scRNAseq datasets spatial transcriptome datasets PLIN2 found promote macrophage transformation M2 subtype Clinical specimen tissue microarrays confirmed differential expression prognostic value PLIN2 CRC patients Functional experiment demonstrated PLIN2 gene overexpression promoted proliferation migration invasion CRC cell significantly facilitated tumor growth vivo Mechanistically revealed CD36 potential downstream target gene PLIN2 CD36 inhibitor SulfoNsuccinimidyl Oleate significantly reversed PLIN2induced proliferation migration invasion EMT activity CRC cell vitro vivo Immunoprecipitation immunofluorescence experiment confirmed PLIN2 could interact CD36 PLIN2 stabilized CD36 protein expression inhibiting proteasomal degradation pathway thereby promoting CD36mediated EMT activity Overall study highlight PLIN2CD36 axis regulates EMT activity CRC progression suggesting intervention signaling pathway may offer promising therapeutic approach CRC progression Schematic diagram elucidating role PLIN2 CRC Figdraw FA transported cell via CD36mediated endocytosis CRC cells PLIN2 promotes stability CD36 interacts CD36 activate EMT process However CD36 inhibitor SSO inhibits binding FAs CD36 attenuates endocytosis thereby reversing PLIN2mediated EMT process Ultimately PLIN2induced enhancement CRC cell proliferation migration invasion attenuated CD36 inhibitor SSO",
        "mesh_terms": [
            "Humans",
            "Colorectal Neoplasms",
            "Epithelial-Mesenchymal Transition",
            "Disease Progression",
            "Animals",
            "CD36 Antigens",
            "Mice",
            "Cell Proliferation",
            "Perilipin-2",
            "Cell Line, Tumor",
            "Cell Movement",
            "Prognosis",
            "Gene Expression Regulation, Neoplastic",
            "Female",
            "Male",
            "Mice, Nude",
            "Mice, Inbred BALB C"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40640171/",
        "source_type": "Global"
    },
    {
        "pmid": "40638114",
        "title": "Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum.",
        "abstract": "trajectory core Alzheimer disease AD cerebrospinal fluid CSF biomarkers concurrent cognitive change across clinical spectrum remain unclear yet important clinical trial design map longitudinal CSF amyloid tau cognitive trajectory along clinical spectrum AD amyloidnegative controls longitudinal cohort study included participant minimum 2 CSF sample Alzheimer Centrum Amsterdam cohort across AD clinical spectrum ie abnormal amyloid level first visit different clinical stages cognitively normal control initially normal CSF marker November 2003 July 2019 maximum followup period 195 year median IQR 2 03 years Data analyzed March 2024 May 2025 AD biomarkers ßamyloid Aß142 Aß140 ratio total tau ttau phosphorylated tau ptau detected serially collected CSF CSF AD biomarkers measured Lumipulse G600II Cognition measured using MiniMental State Examination MMSE delayed memory recall component Rey Auditory Verbal Learning Test Analysis conducted using linear mixed models including random intercept slopes adjusting age education level sex model included interaction term time clinical stage study stagespecific slopes Biomarker conversion rate per clinical stage studied comparing biomarker status visits sample included 197 individual 103 male 523 including 83 control mean SD age 63 8 years 31 individual amyloid positivity cognitively unimpaired mean SD age 67 9 years 30 individual amyloidpositive mild cognitive impairment MCI mean SD age 67 7 years 53 individual amyloidpositive dementia mean SD age 65 8 years Aβ142140 ratio decreased control β SE  855 × 104 187 × 104 P  001 amyloidpositive cognitively unimpaired group β SE  105 × 103 314 × 104 P  001 remained low amyloidpositive MCI dementia groups 10 control 120 reached abnormal amyloid mean SD 48 34 years controls CSF ttau β SE  849 255 pgmL per year P  002 ptau β SE  136 041 pgmL per year P  001 level increased time level also increased amyloidpositive cognitively unimpaired ttau β SE  1724 458 pgmL per year P  001 ptau β SE  310 072 pgmL per year P  001 amyloidpositive MCI ttau β SE  3080 599 pgmL per year P  001 ptau β SE  440 093 pgmL per year P  001 groups ttau increasing dementia group β SE  2497 780 pgmL per year P  002 Longitudinal increase ptau ttau steeper amyloidpositive cognitively unimpaired MCI group controls 10 control 120 reaching abnormal ptau 12 control 145 reaching abnormal ttau levels Delayed recall declined amyloidpositive cognitively unimpaired group β SE  031 007 P  001 associated CSF amyloid level β SE  10229 4730 P  03 MMSE score declined individual amyloidpositive MCI β SE  125 012 P  001 dementia β SE  189 013 P  001 cohort study CSF amyloid decreased toward abnormal level controls declined amyloidpositive cognitively unimpaired group  concurrent decline delayed recall CSF amyloid stabilized amyloidpositive MCI dementia tau marker became increased ie abnormal amyloidpositive cognitively unimpaired amyloidpositive MCI groups suggesting increase CSF tau requires abnormal amyloid",
        "mesh_terms": [
            "Humans",
            "Alzheimer Disease",
            "tau Proteins",
            "Male",
            "Female",
            "Biomarkers",
            "Amyloid beta-Peptides",
            "Aged",
            "Longitudinal Studies",
            "Peptide Fragments",
            "Middle Aged",
            "Aged, 80 and over",
            "Cognitive Dysfunction",
            "Disease Progression"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40638114/",
        "source_type": "Global"
    },
    {
        "pmid": "40637813",
        "title": "Evaluation of a Multiplex Electrochemiluminescence Assay for Detection of Anti-Pneumococcal Antibodies in the Diagnosis of Selective Polysaccharide Antibody Deficiency.",
        "abstract": "Streptococcus pneumoniae responsible severe infections especially patient primary antibody deficiency like selective antipolysaccharide antibody deficiency SPAD reference method recommaned World Health Organization assessment antipneumococcal capsular polysaccharide PCPs IgG antibody standardized serotypespecific ELISA WHOSSA manual method timeconsuming limit number evaluated PCPs aim evaluate performance value multiplex assay based electrochemiluminescence ECLplex panel 164 serum 82 patient sampled 48 week immunization 23valent pneumococcal polysaccharide vaccine PPV23 assessed reference WHOSSA 7 13 serotypes 18plex ECL assay 18 serotypes patient normal serum Igsubclasses level classified good n  43 poor responder n  39 ie SPAD patients according American Academy Asthma Allergy Immunologys AAAAI current guidelines observed excellent correlation two method antiPCPs titer 7 serotypes r  088 95 CI 087090 n  124 sera 13 serotypes r  087 087089 n  40 sera Using AAAAIs guideline interpretation test performance 18plex ECL assay SPAD diagnosis showed sensitivity 95 specificity 84 positive negative predictive value 84 95 respectively percentage agreement 89 SSA 18plex ECL assay 18plex ECL assay reliable rapid simple method evaluating antiPCPs response screening SPAD diagnosis",
        "mesh_terms": [
            "Humans",
            "Antibodies, Bacterial",
            "Streptococcus pneumoniae",
            "Luminescent Measurements",
            "Male",
            "Female",
            "Adult",
            "Pneumococcal Vaccines",
            "Middle Aged",
            "Adolescent",
            "Pneumococcal Infections",
            "Immunoglobulin G",
            "Child",
            "Young Adult",
            "Aged",
            "Polysaccharides, Bacterial",
            "Sensitivity and Specificity",
            "Immunologic Deficiency Syndromes",
            "Electrochemical Techniques",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40637813/",
        "source_type": "Global"
    },
    {
        "pmid": "40636645",
        "title": "Elevated Adrenocorticotropic Hormone After Adrenalectomy or Adrenal Ablation and Immune Checkpoint Inhibitors: Adrenal Insufficiency Is Not Always the Culprit.",
        "abstract": "Adrenal insufficiency known complication immune checkpoint inhibitor ICIs resection ablation adrenal glands modern era immunotherapy frequent assessment adrenal hormonal axis performed initiation ICIs order monitor complications interpretation laboratory tests elevated adrenocorticotropic hormone ACTH patient receive ICIs undergo adrenalectomy adrenal ablation provides additional set diagnostic challenge well described present case series four patient elevated ACTH without clinical symptoms biochemical decreased cortisol evidence adrenal insufficiency pattern suggesting compensatory increase ACTH highlight emerging phenomenon diagnostic challenge monitoring adrenal axis patient undergoing adrenalectomy ablation alongside ICI therapy emphasizing need close followup thorough investigation rule adrenal insufficiency patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40636645/",
        "source_type": "Global"
    },
    {
        "pmid": "40635807",
        "title": "Perioperative challenges and management strategies for non-cardiac surgery in patients with rheumatic heart diseases: A narrative review.",
        "abstract": "Rheumatic heart disease RHDs impose substantial global burden primarily affecting individual 25 year age low mediumincome country LMICs poor marginalized group highincome countries123 underlying cause group betahemolytic streptococcus trigger immunemediated attack heart joints Although acute rheumatic fever ARF treatable occurrence complication remain high impoverished areas4 Variations social structure contribute difference incidence progression disease even affluent regions5 Administering anesthesia patient population present significant challenges particularly early management inadequate due limited medical care followup Literature show evidence anesthetic management different type RHDs mostly focusing mitral aortic valvulopathies67 review synthesizes literature database MEDLINE PubMed search year 2000 date focusing anesthesia management strategy challenge posed ARF RHD Specific topic covered include diagnosis management ARF acute complications perioperative care patient RHD unique consideration different valvular pathologiesWith review aim discus available evidence current World Health Organization WHO societal guideline context perioperative medical anesthetic management hemodynamic challenges postoperative courses emphasis basic pointofcare ultrasound POCUS training made review current era diagnostics therapeutic increasingly reliant echocardiography",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40635807/",
        "source_type": "Global"
    },
    {
        "pmid": "40633814",
        "title": "Increasing the Rates of Postpartum Measles, Rubella, and Varicella Vaccination in Nonimmune Mothers: An Electronic Medical Record-Based Quality Improvement Intervention.",
        "abstract": "Postpartum measles mumps rubella MMR varicella vaccination critical nonimmune mother prevent severe maternal neonatal complications Despite recommendations vaccination rate remain suboptimal particularly completing twodose series study evaluates impact electronic medical record EMRbased intervention postpartum MMR varicella vaccination ratesA retrospective cohort study conducted two urban tertiary care centers Nonimmune postpartum patient public insurance delivered January 2021 June 2022 February 2023 October 2024 included pre postintervention groups respectively intervention implemented April 2023 modified mandated postpartum checklist EMR include measles immunity status emphasize necessity completing twodose series MMR varicella primary outcome completion rate twodose series secondary outcome assessing provider adherence patient acceptance Statistical analysis included chisquared ititests compare pre postintervention cohortsA total 468 patient included 220 preintervention 248 postintervention MMR series completion significantly increased 23 349 ipi  0001 Varicella series completion showed nonsignificant upward trend 270 365 ipi  0112 Provider adherence improved fewer missed opportunity offer second dose postpartum visit 496 vs 329 ipi  0004 MMR Patient declination rate remained stableIntegrating vaccination reminder EMR significantly improved postpartum MMR series completion varicella rate showed modest increase persistent provider followup patient education remain crucial Future effort focus addressing systemic barrier enhancing patient outreach optimize postpartum vaccination completion · EMR checklist improved MMR series completion rates · Varicella series completion showed modest improvement · Provider adherence vaccine guideline increased · Barriers postpartum vaccine completion still exist",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40633814/",
        "source_type": "Global"
    },
    {
        "pmid": "40629311",
        "title": "Teachers' demographics, mindfulness skills, and anxiety predict COVID-19 vaccination status.",
        "abstract": "Given maintaining health teacher student utmost importance study explored potential predictor US teachers decision receive COVID19 vaccine evidencebased public health measure present study explored whether teachers demographic ie gender race age grade taught personal characteristic ie awareness nonjudgmental orientation component mindfulness anxiety state characteristic ie gubernatorial party associated decision receive COVID19 vaccine Five hundred sixteen Kindergarten12th grade teacher across US participated April 2022 Results stepwise generalized linear mixed effect model indicated teacher woman vs men White vs teacher color younger vs older less likely vaccinated Awareness skill associated greater odds vaccination whereas nonjudgmental orientation anxiety associated reduced odds vaccination study provides insight demographic personal statelevel influence associated teachers decision receive COVID19 vaccine Findings highlight importance targeted effort increase adherence public health guideline school reopen swiftly safely future public health crises",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "School Teachers",
            "Anxiety",
            "Mindfulness",
            "COVID-19",
            "Adult",
            "COVID-19 Vaccines",
            "United States",
            "Middle Aged",
            "Vaccination",
            "Demography"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40629311/",
        "source_type": "Global"
    },
    {
        "pmid": "40628565",
        "title": "Factors Associated with Immune Effector Cell-Associated Neurotoxicity Syndrome in Adults with Hematological Malignancies Undergoing Chimeric Antigen Receptor T-Cell Therapy: A Systematic Review.",
        "abstract": "systematically appraised study investigating factor associated ICANS development CART cell therapy adult hematological malignancy estimated ICANS prevalence conducted systematic review SR 4 database following PRISMA Preferred Reporting Items Systematic Reviews MetaAnalyses guideline study published 2010 December 2024 estimated ICANS prevalence exact binomial score testbased 95 confidence intervals applied FreemanTukey double arcsine transformation stabilize variance within randomeffects model using Metaprop command Stata Sixteen study 14 retrospective n  135 2 prospective n  300 included SR sample comprised adult various hematological malignancy received antiCD19 antiBCMA clinical factor seem associated ICANS incidence severity retrospective studies pooled prevalence 41 95 CI 3151 grade ICANS 20 95 CI 1328 grade ≥3 ICANS prospective studies pooled prevalence 51 95 CI 4556 Approximately half hematological patient undergoing CAR therapy develop ICANS Although factor may contribute development ICANS limited study samples retrospective nature majority studies discordance among result preclude certain risk factor conclusions Nurses play pivotal role posttreatment monitoring early detection management ICANS given direct continuous patient interaction Increasing nurses awareness potential risk factor ICANS enhance vigilance effectiveness managing condition",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40628565/",
        "source_type": "Global"
    },
    {
        "pmid": "40624614",
        "title": "Superiority of pan-immune inflammation value, systemic inflammation index, and CALLY scores prognostic value for mortality of ischemic stroke patients followed in intensive care unit.",
        "abstract": "Inflammatory response play important role pathophysiology prognosis ischemic stroke Hyperinflammation progress aggravation brain damage deterioration clinical status study aimed demonstrate valuable easytoobtain inexpensive parameter prognostic assessment comparing Panimmune Inflammation Value PIV Systemic ImmuneInflammation Index SII CALLY score patient ischemic stroke retrospective singlecenter cohort study file patient followed diagnosis ischemic stroke tertiary intensive care units Multivariate regression analysis receiver operating characteristic curvesROC used detect association PIV SII CALLY inhospital mortality superiority predicting mortality ischemic stroke patients 1039 patients 453 died resulting overall survival rate 564 multivariate analysis high APACHE II score low albumin level remained independent risk factors ROC curve showed PIV SII CALLY exhibited good predictive values AUCs 0921 0887 0930 95 CI 09030936 08550896 09130945 p  0001 pairwise comparison data based AUC value indicated significant difference SII PIV CALLY p  0001 contrast significant difference found PIV CALLY p  0385 PIV SII CALLY index serve accessible reliable prognostic biomarkers enhance personalized treatment strategy improve clinical decisionmaking patient ischemic stroke",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Prognosis",
            "Ischemic Stroke",
            "Aged",
            "Intensive Care Units",
            "Middle Aged",
            "Retrospective Studies",
            "Inflammation",
            "ROC Curve",
            "Hospital Mortality",
            "Biomarkers",
            "Risk Factors",
            "Severity of Illness Index",
            "Aged, 80 and over"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40624614/",
        "source_type": "Global"
    },
    {
        "pmid": "40624367",
        "title": "EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma.",
        "abstract": "Since publication 2021 European Hematology Association EHA Clinical Practice Guidelines treatment patient smouldering multiple myeloma SMM multiple myeloma MM developed collaboration European Society Medical Oncology novel international staging system R2ISS developed several prognostic factor entering clinical practice such minimal residual disease circulating plasma cell monoclonal protein assessed mass spectrometry and time writing 14 novel regimen approved EMA andor FDA treatment patient MM multidisciplinary group expert EHA European Myeloma Network based various institution mostly located Europe updated previous guideline produced algorithm everyday clinical practice incorporate level evidence grade recommendation based aforementioned new data EvidenceBased Guidelines provide key treatment recommendation patient newly diagnosed MM relapsed andor refractory MM including guidance use established drug well contemporary immunotherapies Novel approach management patient SMM focus might require early intervention Finally provide recommendation myelomarelated complication adverse events bone disease renal impairment infections well associated cellmobilizing therapies cytokinerelease syndrome immune effector cellassociated neurotoxicity syndrome",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40624367/",
        "source_type": "Global"
    },
    {
        "pmid": "40623795",
        "title": "Real-world effectiveness study of guideline-directed COPD STANDARDized management in patients with chronic obstructive pulmonary disease: a cluster randomised trial design.",
        "abstract": "Chronic obstructive pulmonary disease COPD affect ageing population worldwide Exacerbations worsen health status increase health resource use Existing guideline recommend disease management fully implemented clinical setting Evidence regarding best practice realworld effectiveness limited nationwide multicentre clinical effectiveness trial performed 2023 2027 involving 99 secondary hospital urban rural area China openlabel adjudicator assessorblinded parallel group cluster randomised pragmatic trial Hospitals randomly allocated standardised management SM usual care total number 3456 stable patient COPD symptomatic individuals Global Initiative Chronic Obstructive Lung Disease GOLD Group B exacerbation risk individuals one moderate exacerbation history Group individual Group E using GOLD 2023 ABE classification enrolled SM group integrated intervention comprising five component delivered using physician nurse model are 1 longterm inhaled maintenance therapy 2 periodic inhaler technique assessment symptom monitoring 3 annual pulmonary function testing 4 COPD education session 5 health behaviour adoption smoking cessation vaccination pulmonary rehabilitation control group patient receive routine care primary goal assess realworld effectiveness guidelinedirected disease management exacerbation prevention moderatetosevere exacerbation primary outcome hospital admission mortality health status COPD selfmanagement secondary outcomes first pragmatic trial undertaken form developing country anticipated provide feasible effective COPD management model inform guideline rolled secondary primary care modification ensure standardised COPD care nationwide NCT04664491",
        "mesh_terms": [
            "Humans",
            "Male",
            "China",
            "Disease Progression",
            "Practice Guidelines as Topic",
            "Pragmatic Clinical Trials as Topic",
            "Pulmonary Disease, Chronic Obstructive"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40623795/",
        "source_type": "Global"
    },
    {
        "pmid": "40620437",
        "title": "Unraveling cutaneous histiocytosis: insights into histology, pathogenesis, diagnosis, and treatment pitfalls.",
        "abstract": "Histiocytoses represent group diverse rare disorder characterized abnormal accumulation cell derived mononuclear phagocyte system various tissue organs mononuclear phagocyte system includes monocytes macrophages dendritic cells specialized tissueresident phagocytes cell essential innate adaptive immunity preserving tissue homeostasis Several classification histiocytoses Histiocyte Society 1987 1997 2016 2018 2022 International Consensus Classification 2022 generally acknowledged 2022 classification clarifies heterogeneous disorder dividing three major groups Cutaneous involvement histiocytosis often polymorphous making clinical decision challenging Cutaneous histiocytoses occur either primary case manifestation multisystemic disease support standard pathology report immunohistochemical staining warranted exact etiopathogenesis histiocytoses remains poorly understood various association malignancies including visceral hematologic cancers well autoimmune disease infection Borrelia burgdorferi still review One recent advancement field discovery somatic mutation RAFMEKERK signaling pathway particularly BRAF mutations Oncogeneinduced senescenceassociated BRAF mutation described Langerhans cell histiocytosis ErdheimChester disease Targeted therapy BRAF inhibitor dabrafenib vemurafenib shown promising results MEK inhibitors like trametinib cobimetinib demonstrated efficiency regardless BRAF mutation status Local treatment cutaneous histiocytosis include topical steroids calcineurin inhibitors alkylating agents phototherapy steroid injections laser therapies Despite current advance pathogenesis treatments cutaneous histiocytosis stand challenging heterogeneous group disorders treatment guideline warranted",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40620437/",
        "source_type": "Global"
    },
    {
        "pmid": "40619406",
        "title": "Meta-analysis of TB & HIV co-infection mortality rate in sub-Saharan African children, youth, and adolescents.",
        "abstract": "Despite effectiveness antiretroviral treatment ART reducing morbidity mortality child adolescent coinfections face elevated risk death due young age compromised immune systems risk factor tuberculosis TB adverse TB outcome HIVinfected adult welldocumented mortality estimation understanding mortality risk among HIVinfected child adolescents especially era test treatment universal ART HIVinfected persons remains limited study aimed estimate mortality rate among TB HIVcoinfected child SubSaharan African country using SRM systematically searched relevant study seven international electronic databases Articles searched using Preferred Reporting Items Systematic Reviews MetaAnalyses PRISMA guidelines Article searching included six electronic database including PubMedMEDLINE N  1287 Scopus N  447 Web Science N  174 Science Direct N  749 Cochran N  57 Google Scholar research repository base searching N  42 quality primary study evaluated using Joanna Briggs Institute JBI checklist pooled mortality rate estimated using weighted inverse variance randomeffect metaanalysis Heterogeneity among study assessed using Cochrans Q test estimated using I2 statistic document registered Prospero CRD420251012913 SRM 16 individual study included coinfected mortality screening 5098 participants 657 death reported cotreatment started pooled mortality burden estimated 1296 95 CI 894 1698 I2  926 P  0001 majority TB coinfected case newly diagnosed ART started final weighted inverse variance randomeffect regression indicated stage III IV pooled HR  434 poor fair ART adherence pooled HR  311 missed Isoniazid preventive therapy IPT pooled HR  307 hemoglobin level ≤ 10 mgdL pooled HR  284 bedridden functional status pooled HR  319 threshold CD4 count pooled HR  180 missed cotrimoxazole preventive therapy CPT pooled AOR  158 predictor premature death coinfection review overall pooled burden mortality HIVinfected child SSA country high compared End TB Strategy target estimation Significant predictor mortality included clinical stage III IV poor fair ART adherence missed Isoniazid preventive therapy IPT hemoglobin level ≤ 10 mgdL Therefore counseling antiretroviral therapy adherence strengthened early screening treating anemia screening scaling IPT critical ART drug nutritional counseling done regular visit caregiver prevent premature death among children youths adolescent coinfection SSA",
        "mesh_terms": [
            "Humans",
            "Africa South of the Sahara",
            "Adolescent",
            "HIV Infections",
            "Child",
            "Coinfection",
            "Tuberculosis",
            "Male",
            "Female",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40619406/",
        "source_type": "Global"
    },
    {
        "pmid": "40615433",
        "title": "An international multi-cohort investigation of self-reported sleep and future depressive symptoms in older adults.",
        "abstract": "Poor subjective sleep associated future depression older adults limited consensus sleep feature strongest associations Moreover composite score incorporating multiple feature may better represent sleep burden individual sleep items analyzed older adult age ≥ 60 without clinically relevant depressive symptom multicohort United States sample US N  4826 Netherlands Rotterdam Study RS N  3663 goal identifying individual composite sleep feature associated future clinically relevant depressive symptom 36 year later Sleeprelated daytime symptom Risk Ratio 95 CI 210 158 280 US 210 140 314 RS difficulty falling asleep 187 149 235 US RS  190 150 243 RS strongest individual sleep features Moreover combination feature impactful 332 233 473 US 319 264 386 RS providing largest effect size fewest number items Future study assess whether screening tool incorporating features paired targeted sleep treatment could reduce rate incident depression older adults Examining mechanism underlying association could improve effectiveness sleeprelated treatment older adults",
        "mesh_terms": [
            "Humans",
            "Aged",
            "Male",
            "Female",
            "Depression",
            "Self Report",
            "Sleep",
            "Middle Aged",
            "Cohort Studies",
            "United States",
            "Netherlands",
            "Sleep Wake Disorders",
            "Aged, 80 and over",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40615433/",
        "source_type": "Global"
    },
    {
        "pmid": "40613758",
        "title": "Beneficial effects of aerobic exercises on multiple myeloma: Mechanisms and clinical observations.",
        "abstract": "Studies multiple myeloma MM second common hematologic malignancy shown inconclusive result regarding role exercise treatment study evaluated relationship physical exercise MM treatment outcomes 5TMM mouse model tumorbearing mouse underwent treatment included bortezomib dexamethasone alongside 6 week low moderateintensity treadmill aerobic training Tumor burden survival data recorded Additionally retrospective analysis conducted 65 MM patient undergoing maintenance therapy West China Hospital 2013 2024 Patients categorized based adherence World Health Organization WHO physical activity guidelines progressionfree survival progressionfree survival maintenance therapy analyzed mouse model combination dualdrug therapy exercise improved outcomes extending survival 10 days Aerobic exercise reduced regulatory cell increased NK cell peripheral blood mice exercise group mice myokines IL15 irisin upregulated implying myokines could contribute regulation antiMM immunity patient study patient met physical activity recommendation demonstrated significantly better progressionfree survival PFS progressionfree survival maintenance treatment PFSm Overall appropriate aerobic exercise may benefit MM patients suggesting potential exercise adjunct MM treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40613758/",
        "source_type": "Global"
    }
]